$startl$,dossier,guideline,PDF link ,study: Acute toxicity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,,,,In vivo ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,,,,non OECD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OECD 401 ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OECD 402,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OECD 403,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,,,,Endpoints ,,,,,,,,grading of lesion,,Test method,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,reliability,,,,,,,,additional information,own comments,,Endpoints,,,,,,,,,,,,,,,Test method,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Reliability,,,,,,,additional information,own comments,,Endpoints,,,,,,,,,,,Test method,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Reliability,,,,,,additional information,own comments,,Endpoints,,,,,,,,,,,,Test method,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Reliability,,,,,,,additional information,own comments,$endl$
$startl$,,,,target organ at necroscopy,observations and recording,dose descriptor ,dose descriptor unit,moribund or dead animals prior to study termination ,mortality rate,conclusion,,,,test substance ,,,,,,,,,,,,test species in in vivo study,,,,,,,,,,test conditions acute txicity,,,,,,,,,,,,,,,,,,,SCCS comment to test,year,control groups,GLP,preliminary test,Klimisch score,Ref. in dossier,,,,,Observations ,,,,,,LD50 (mg/kg),95% confidence interval ,LD50 male (mg/kg),LD50 female (mg/kg),moribound or dead  male animals prior to study termination,mortality rate in males,moribound or dead  female animals prior to study termination,mortality rate in females,conclusion,,Test substance,,,,,,,,,Experimental animals,,,,,,,,,,,,Test conditions,,,,,,,,,SCCS comment to test,year,control groups,GLP,limit test,klimisch score,ref. in dossier,,,,Observations ,,,LD50 (mg/kg),95% confidence interval ,LD50 male (mg/kg),LD50 female (mg/kg),moribound or dead animals prior to study termination,mortality rate ,conclusion,,Test substance,,,,,,,,,Experimental animals,,,,,,,,,,,,Test conditions,,,,,,,,,SCCS comment to test,year,control groups,GLP,klimisch score,ref. in dossier,,,,Observations ,,,LC50 ,LC50  unit ,95% confidence interval ,LC50 male,LC50 female,moribound or dead animals prior to study termination,mortality rate ,conclusion,,Test substance,,,,,,,,,,,Experimental animals,,,,,,,,,,,Test conditions,,,,,,,,,,,,,,,SCCS comment to test,year,control groups,GLP,limit test ,klimisch score,ref. in dossier,,,$endl$
$startl$,,,,,,,,,,,,,,homogeneity and stability,treatment prior to application,pH,"physical form (solid, liquid, aerosol, dust)",concentration (% nominal and actual),composition,purity (%),solubility in vehicle,chemical batch nr,particle size ,additional info,,species/strain,source,age at start of experiment ,"age measuring unit (day, week, month, year)","sex (female, male)",weight,"weight measuring unit (gram, kilogram)",feed,n animals / dose,,dose levels,dose level unit ( or extra info),administration scheme,route of exposure,,,,,,,,dose volume ml/kg bw,rinsing procedure,use of anaesthetics and analgesics,vehicle name,vehicle concentration %,exposure time (hour),observation period (day),,,,,,,,,,,,,clinical examiniation in males,gross pathology in males,microscopic pathology in males,clinical examiniation in females,gross pathology  in females,microscopic pathology in females,,,,,,,,,,,pH and adjustment,physical form ,concentration (%),composition,purity (%),solubility in vehicle,chemical batch nr,additional info,,Species,,source,Age,,Weight,,,sex,housing and feeding,n animals / group,,dose levels value,dose levels unity,dose volume (ml/g),administration scheme,Route of exposure,Vehicle,,observation period  + recovery period (day),,,,,,,,,,,,clinical examiniation ,gross pathology ,microscopic pathology ,,,,,,,,,pH and adjustment,physical form ,concentration (%),composition,purity (%),solubility in vehicle,chemical batch nr,additional info,,Species,,source,Age,,Weight,,,sex,housing and feeding,n animals / group,,dose levels value,dose levels unity,dose volume (ml/g),Dermal exposure,,Vehicle,,observation period,,,,,,,,,,,clinical examiniation ,gross pathology ,microscopic pathology ,,,,,,,,,,pH and adjustment,physical form ,treatment prior to use,"particle size, distribution, shape and density",concentration (%),composition,purity (%),solubility in vehicle,chemical batch nr,additional info,,species/strain,source,Age,,Weight,,,sex,housing and feeding,n animals / group,,nominal dose levels value,nominal dose levels unity,actual dose levels value,actual dose levels unit,Inhalation exposure,,,,,exposure time (hour),observation period (day),Equipment measuring ,,,,,,,,,,,,,$endl$
$startl$,,,,,,,,,, ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"oral (gavage, drink water, feed)",dermal,body surface area,"patching technique ( open, semi-occluded, occluded)",skin condition,"inhalation (nose (head) -only, whole body)",occular,other,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"rodent/strain ( rat, mouse, …)","non-rodent/strain ( dog, rabbit, primate, …)",,age value at start of experiment ,"age unit ( days, weeks, months, years)",male mean weight value ,female mean weight value ,"mean weght unit (g, kg)",,,,,,,,,"oral ( gavage, intubation cannula, stomach tube)",vehicle name,vehicle concentration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"rodent/strain ( rat, mouse, …)","non-rodent/strain ( dog, rabbit, primate, …)",,age value at start of experiment ,"age unit ( days, weeks, months, years)",male mean weight value ,female mean weight value ,"mean weght unit (g, kg)",,,,,,,,body surface,"patching technique ( occluded, semi-occluded)",vehicle name,vehicle concentration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,age value at start of experiment ,"age unit ( days, weeks, months, years)",male mean weight value ,female mean weight value ,"mean weght unit (g, kg)",,,,,,,,,Exposure apparatus,,,,air flow rate,,,humidity,temperature,particle size and concentration,,,,,,,,,,,$endl$
$startl$,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,design ,type,dimension,source of air,,,,,,,,,,,,,,,,,$endl$
$startl$,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,DATA TYPE:,OECD XXX/non OECD,DATA TYPE:,text or tabulated data (as images),txt,number,txt,yes/no,txt,text,,txt,,text,,numbers,txt,numbers/txt,text,txt,text,number/txt,txt,text,,text,text,number,txt,text,number,txt,text,text/number,,numbers,txt,text/number,yes/no (list),yes/no,text,text,text,yes/no ( list),yes/no,,numbers,txt,txt,text,number,txt,number,,text,number,txt,yes/no,txt,number,txt,,text,text,,txt,txt,txt,txt,txt,txt,num,num,num,num,yes/no,txt,yes/no,txt,txt,,txt,"from {solid,liquid}",,txt,num,,txt,txt,,txt,txt,txt,num,"from {days, weeks, months, years}",num,,"from {g,kg}","from {f, m, f&m}",txt,num,,num,txt,num,"from {single dose, fractions over 24h}","from {gavage, intubation cannula, stomach tube}",txt,num,num,,txt,num,txt,yes/no,txt,num,txt,txt,txt,,txt,txt,txt,num,num,num,num,yes/no,txt,txt,,txt,"from {solid,liquid}",,txt,num,,txt,txt,,txt,txt,txt,num,"from {days, weeks, months, years}",num,num,"from {g,kg}","from {f, m, f&m}",txt,num,,num,txt,num,num,"from{occluded, semi-occluded}",txt,num,,,,,,,,,,,,txt,txt,txt,num,"from {mg/l, ppm}",,num,num,yes/no,txt,txt,,txt,"from {volatile, aerosol/particulate, nano-material}",txt,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"1,2,4-trihydroxybenzene ",non OECD,https://ec.europa.eu/health/sites/health/files/scientific_committees/consumer_safety/docs/sccs_o_113.pdf,,"based on the observed mortality rates, the LD50 figure was calculated using three methods (probit method, litchfield & wilcoxon´s method, arcsinus method). ",350 - 500,"LD50, between the mentioned numbers in mg/kg bw",yes,death occurred within 24 hours after substance administration,,,,,,,,,1,test substance in  the vehicle,,,,,,,rat/ofa(sprague-dawley derived),,,,f & m,,,,10,,"100, 250, 350, 500, 1000 ",mg/kg bw,,"yes,gavage",,,,,,,,,,,carboxymethylcellulose/water,,,14,,"the description of the procedure was very short. it was not possible to compare the method used with OECD 401. there was no information on the batch that was tested, the study was not carried out according to glp, and no data were presented on the development of the body weights. additionally, the study protocol did not include a necropsy. however, the outcome of this study adds some information on the toxicity of the compound",,,no,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"1,2,4-trihydroxybenzene ",OECD 402,https://ec.europa.eu/health/sites/health/files/scientific_committees/consumer_safety/docs/sccs_o_113.pdf,,"from day 2 after removal of the dressings, hypoactivity, piloerection and dyspnea were observed in all females until day 8. 1 of 5 females showed tremors. the overall body weight gain of 9/10 animals was similar to the historical control animals, one female showed a slightly reduced body weight gain during the second week of the study. a black coloration of the skin was noted in all animals from day 2 until day 15 (end of study). an erythema was observed in 2/5 males on day 2 and persisted in one of them on day 3. an oedema was recorded between day 2 and day 5 in 2/5 males and all females between day 2 and day 6. no apparent abnormalities were noted at necropsy in any animal. ",,,no,,"the maximal non-lethal dose of 1,2,4-trihydroxybenzene was 2000 mg/kg bw by dermal route in rats. ",,,,,,,,1,test subtance in carboxymethylcellulose/water,98.1,,506382,,,,rat/sprague-dawley,,,,f & m,,,,10,,2000, mg/kg bw,single ,,yes,,semi-occluded,,,,,,,,,,24,14,,,,,yes,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,phenoxyethanol,OECD 401,http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_195.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"all male animals dosed with 681 mg/kg bw survived the 14-day observation period. all males survived a treatment of 1470 mg/kg bw. clinical signs included dyspnoea, apathy, abnormal posture, staggering, atony, deficiency in pain and cornea reflex, coma-like state, spastic gait, rough fur, exsiccosis, exophthalmoses, and general poor condition.",,,"all female animals dosed with 681 mg/kg bw survived the 14-day observation period.  clinical signs included dyspnoea, apathy, abnormal posture, staggering, atony, deficiency in pain and cornea reflex, coma-like state, spastic gait, rough fur, exsiccosis, exophthalmoses, and general poor condition. generally females were more susceptible to 2- phenoxyethanol than males.",animals that died during the study course revealed the following signs at necropsy: hyperaemic congestion; lungs which were slightly inflated; sporadically reddened glandular stomach.,,2740,,4070,1840,yes," in all treatment groups, the latest time point where death occurred was observation day 1. at a dose level of 3160 mg/kg bw, 2 males died. at the highest dose level 3 males died. ",yes," in all treatment groups, the latest time point where death occurred was observation day 1. 2 out of 5 female rats died at 1470 mg/kg bw, at a dose level of 3160 mg/kg bw, 4 females died. at the highest dose level all females died.",,,,,,,80,,82/135,,,rat/wistar,,,,,,,,f & m,,10,,"681, 1470, 3160, 5000",mg/kg bw,,single ,gavage,carboxymethylcellulose,0.5,14,,"although this study was not conducted under GLP and the concentration of the test substance was reported as ca. 80%, the study is considered sufficiently reliable for evaluation of the endpoint of acute oral toxicity.",1982,,no,,2,1," two other acute oral toxicity studies in rats and rabbits, which dated from 1980 and were poorly documented, resulted in LD-50 values of 1- 2 g/kg bw.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,phenoxyethanol,non OECD,http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_195.pdf,,"gross necropsy revealed no gross pathological findings in any of the major organs evaluated including heart, lungs, brain, gastrointestinal tract, liver, and spleen. local erythema at the site of application was observed in two rabbits and was reversible within 3 days after dosing. desquamation was observed at the site of application in one rabbit from days 3-14 after dosing. ",>2214,"LD50, mg/kg bw",no,"3 out of 5 female rats died at 1470 mg/kg bw, at a dose level of 3160 mg/kg bw, 2 males and 4 females died, respectively. at the highest dose level 3 males and all females died.",sufficiently reliable for evaluation of the endpoint of acute dermal toxicity although the study wasn't conducted under glp and the test substance purity was not reported,,,,,,,,,,,,2219-93,,test substance: emeressence 1160 (2-phenoxyethanol),,rabbit/new zealand white,,,,f & m,,,,4,,2214,mg/kg bw,single,,yes,dorsal ,occluded,damaged,,,,2,,,undiluted,,24,14,,"lack of any gross pathological alterations or lesions is reported in all standard organs following dermal application, however, these were not investigated in the kidney.",1980,,no,,,2,,guideline: pre-OECD ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,vitamin a,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_199.pdf,,"the surviving animals gained weight. necroscopy showed acute dilation of heart including congestion, discoloured liver with broaded lobes, irritated gastro-intestinal tract. those rats which were sacrificed at the end of the 21-day observation period did not reveal any gross pathologic alterations in the tissues and organs examined.",4980,"LD50, 5290 in males, 4790 in females mg/kg bw",yes,"mortality ratios were calculated after 1, 24 and 48 hours and after 7 and 14 days according to the probit analysis of finney (1971). deaths occurred dose-dependently within 7 days after dosing and signs of intoxication were observed in the animals that died or recovered until termination.",low toxicity in acute oral toxicity studies,,,,,,,,,,"1.53 mio IU/g USP XIX (526 mg RAc/g), not stabilised",,6/17,,test substance: retinyl acetate,,rat/sprague-dawley,,,,f & m,,,animal fasted 15-20h prior to application,10-20,,"3160, 3830, 4640, 5620, 6810, 8250  ","mg/kg bw, first fifth group 10 animals/sex, the highest dosed group 5 animal/sex",single,"yes, gavage",,,,,,,,,,,peanut oil,,,21,,"low toxicity for vitamin a ( retinol, retinyl palmitate, retinyl acetate) with the ranking declining in order of retinol> retinyl acetate > retinyl palmitate. these LD50 values are in line with peer-reviewed literature data given for retinol and retinyl esters: retinol: LD50 oral, mouse: 2570 mg RE/kg bw (8.5 mio IU/kg bw) LD50 i.p., mouse: 1510 mg RE/kg bw (5 mio IU/kg bw)/ retinyl acetate: LD50 oral, mouse: 4100 mg/kg bw (11.9 mio IU/kg bw) LD50 i.m., young monkey: 168 mg/kg bw (estimation) (0.49 mio IU/kg bw)/ retinyl palmitate: LD50 oral, mouse: 6060 mg/kg bw (11 mio IU/kg bw) LD50 oral, rat: 7910 mg/kg bw (14.4 mio IU/kg bw).in  general, in case of fatalities, the death was preceded by signs of acute toxicity in form of convulsions and paralysis, and those animals that survived had signs of malaise, decreased motor activity, stupor, muscular weakness, and occasionally changes in the gait. the animals that survived recovered with no apparent residual toxic effects. ",,,no,,,7,,guideline: comparable to OECD 401,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,β-arbutin,OECD TG 401,http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_169.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"the animals were checked daily for mortality and clinical signs. body weights were recorded on days 1 to 5, 7, 8, 11 and 15. liver changes associated with the test substance were observed at 4149 mg/kg bw in mice and at 9641 mg/kg bw in rats, though not at lower dosage levels. few toxic signs were observed in either species at dosage levels up to 3513 mg/kg bw.",,,"the animals were checked daily for mortality and clinical signs. body weights were recorded on days 1 to 5, 7, 8, 11 and 15. liver changes associated with the test substance were observed at 4149 mg/kg bw in mice and at 9641 mg/kg bw in rats, though not at lower dosage levels. few toxic signs were observed in either species at dosage levels up to 3513 mg/kg bw.",,,8715; 9804,,,,yes,"in rats at 1792 (mg/kg bw) :0/5, 2509 (mg/kg bw) :0/5, 3513 (mg/kg bw): 0/5, 4919 (mg/kg bw): 0/5, 6886 (mg/kg bw): 2/5, 9641 (mg/kg bw): 3/5, 13496 (mg/kg bw): 4/5, 18895 (mg/kg bw): 5/5; in mice: 1792 (mg/kg bw) :0/5, 2509 (mg/kg bw) :0/5, 3513 (mg/kg bw): 0/5, 4919 (mg/kg bw): 1/5, 6886 (mg/kg bw): 1/5, 9641 (mg/kg bw): 1/5, 13496 (mg/kg bw): 3/5, 18895 (mg/kg bw): 5/5",yes,"in rats at 1792 (mg/kg bw) :0/5, 2509 (mg/kg bw) :0/5, 3513 (mg/kg bw): 0/5, 4919 (mg/kg bw): 0/5, 6886 (mg/kg bw): 1/5, 9641 (mg/kg bw): 3/5, 13496 (mg/kg bw): 4/5, 18895 (mg/kg bw): 5/5; in mice 1792 (mg/kg bw) :0/5, 2509 (mg/kg bw) :0/5, 3513 (mg/kg bw): 0/5, 4919 (mg/kg bw): 0/5, 6886 (mg/kg bw): * 1/4, 9641 (mg/kg bw): 3/5, 13496 (mg/kg bw): 3/5, 18895 (mg/kg bw): 5/5. * one of the five 6886 mg/kg bw female mice died by gavage accident",low level of acute oral toxicity in both rat and mouse,,,,,,99.7,,lot A,,,rat/sprague dawley; mouse/icr,,,,,,,,f & m,,10,,"1792, 2509, 3513, 4919, 6886, 9641, 13496, 18895", mg/kg bw,,single ,gavage,,,14,,,1985,,no,,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,β-arbutin,OECD TG 402,http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_169.pdf,," in mouse body weights recorded on day 1 to 3,5 to 8, 12 and 15; in rats on day 1 to 3, 5 to 8 and 15.all animals sacrified with chloroform at the end of observation period",> 928 ,the technically applicable maximal dose,no,,for rats and mice the LD50 value via the dermal route is greater than the technically applicable maximal dose,,,,,,,,30,β-Arbutin 30% in a 50:50 ethanol:water solution,99.7,,lot A,,,,rats/ sprague dawley; mouse/ICR,,,,f & m,,,,20,,928, mg/kg bw,,,yes,on the back after fur clipping,,,,,,3,,,50:50 ethanol:water,,,14,,no justification in relation to the maximum technically feasible dose of  3 ml/kg . according to OECD TG 402 a dose level of 2000 mg/kg is the cut-off for the limit test.,1986,,no,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,zinc pyrithione,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_133.pdf,,"activity decrease, crusted eyes, piloerection, ptosis, respiratory gurgle and sensitivity to touch/sound which were no longer evident in surviving animals by day 10. emaciation was found in one animal that died on test. body weights affected by exposure in surviving animals. abnormal necropsy findings occurred in animals that died on test and consisted of red crust around mouth and dark red andswollen lungs. ",5.08,LC50 mg/l,yes,occurred as follows: 1 of 5 males and 0 of 5 females at 0.68 mg/l; 2 of 5 males and 0 of 5 females at 1.19 mg/l; 2 of 5 males and 1 of 5 females at 2.25 mg/kg. ,,,,,,,,,,zinc omadine dispersion (fps) ,,,,"mmads: 3.2, 2.5 and 2.5 μm",master Log: 74-01B10CuZPT sample 0104241211,,rat/sprague-dawley,,,,f & m,,,,10,,"0.68, 1.19 and 2.25 ",mg/l,,,,,,,yes,,,,,,undiluted,,4,14,,this study shows that systemic effects on hind legs might occur after inhalation exposure,2004,,yes,,,e3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,zinc pyrithione,OECD 403,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_133.pdf,"lung, liver, hind leg","all surviving animals showed signs of toxicity (one of the two surviving females exposed to 1.82 mg/l showed stiffness in the hind legs) which improved until the end of the observation period. except one female exposed to 0.53 mg/l, normal bodyweight development was observed during the second week. lung abnormalities (swelling, pallor, abnormally dark appearance, dark patches and foci) and liver changes (dark appearance) were observed in animals that died. except one female exposed to 0.53 mg/l, no abnormalities were observed in animals that were killed at the end of the observation period.", 0.84; 1.34; 1.03,"LC50, in males; in females; combined mg/l",yes,all deaths occurred on day 1 after exposure as follows: 1 of 5 males and 0 of 5 females at 0.53 mg/l; 3 of 5 males and 2 of 5 females at 0.95 mg/l; 5 of 5 males and 3 of 5 females at 1.82 mg/kg.,"the following LC50 values were derived: males: 0.84 mg/l, females: 1.34 mg/l, males and females combined: 1.03 mg/l. the results of this study lead to classification as acute tox 3; H331 (toxic if inhaled) according to CLP (Regulation (EC) No 1272/2008) by the registrant. ",,,,,,,,,,,, tox 1000 ,"respective mmadss were 3.3 μm at 0.53 mg/l, 3.5 μm at 0.95 mg/l and 3.8 μm at 1.82 mg/l; aerosol dust",label: zinc-pyrion,,rat/sprague-dawley,,,,f & m,,,,10,,"0.53, 0.95, 1.82",mg/l,,,,,,,"yes, nose-only",,,,,,,,4,14,,this study shows that systemic effects on hind legs might occur after inhalation exposure. ,1996,,yes,,,e2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,zinc pyrithione,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_133.pdf,"lungs (in study), no abnormalities (study end)","surviving animals showed signs of toxicity post exposure (decreased activity, salivation, laboured breathing, tremours, staining around the mouth). no visible abnormalities were observed after post-exposure day 5. necropsy of animals which died on study revealed congestion or discoloured lungs: animals necropsied at study termination showed no abnormalities.",<0.6 ,"LC50, mg/l",yes,all deaths occurred on day 1 after exposure as follows: 1 of 5 males and 0 of 5 females at 0.24 mg/l; 1 of 5 males and 2 of 5 females at 0.61 mg/l.,,,,,,,,,,Zinc Omadine® Powder; Id.-No. 10215B ,95,,orc-152-011 dp ,"respective mmads were 1.9 μm at 0.24 mg/l and 2.3 μm at 0.61 mg/l, aerosol dust",,,rat/sprague-dawley,,,,f & m,,,,10,,"0.24, 0.61",mg/l,,,,,,,"yes, nose-only ",,,,,,,,4,14,,"a further whole body inhalation study was performed in which a LC50 value of 0.14 mg/l was derived. classification as acute tox 3 is suggested. sccs notes that classification as acute tox 3; H331 (toxic if inhaled) according to CLP (regulation (EC) No 1272/2008 of the european parliament and of the council of 16 december 2008 on classification, labelling and packaging of substances and mixtures) is suggested by the registrant(s) under REACH (ECHA website (http://echa.europa.eu/).",1991,,yes,,,e25,,guideline: compiles with 403,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,zinc pyrithione,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_133.pdf,,,90-266; 160-1000; 600,"LD50, mg/kg, between mentioned numbers in rat; mouse; dog",,,,,,,,,,,,,,,,,ingredient based ,,"rat, mouse, dog",,,,,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,,"b6, b10, b33, 57, b71, b73",,more info on ECHA's website,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,zinc pyrithione,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_133.pdf,,,2.5; 3.0,"LD50, in rat for a cream shampoo formulation g/kg; for a lotion shampoo ml/kg",,,LD50 in rat for a cream shampoo formulation: 2.5 g/kg; for a lotion shampoo: 3.0 ml/kg,,,,,,,,,,,,,,product derived,,rat,,,,,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,,b61,,"further study with a higher concentration fomulation of a cream shampoo showed higher LD50 concluding higher zpt level, higher oral toxicity",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,zinc pyrithione,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_133.pdf,,"product derived emetic study, in the study with dogs, the emesis typically occurred within 60 minutes of dosing, the average being 30 minutes, and involved two to four episodes. occasional bloody vomitus was seen, indicating gastric irritation.",,,,,zinc pyrithione in a cream shampoo product is a potent emetic (ED50 app. 0.05 g/kg).  the ratios of ED50 to LD50 for both forms of the product are 1:125 for the cream shampoo and 1:42 for the lotion shampoo; therefore it was concluded in that it is unlikely that a human accidentally ingesting shampoo could retain a hazardous amount. ,,,,,,,,,,,,,,,,"dog, pigeon",,,,,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,,"b14, b15, b38",,"in addition to acute oral toxicity studies evaluated in SCCNFP/0671/03 further studies have been performed. the data is not available for evaluation. sccs notes, however, that classification as acute tox 3; H301 (toxic if swallowed) according to CLP (regulation (EC) No 1272/2008 of the european parliament and of the council of 16 december 2008 on classification, labelling and packaging of substances and mixtures is suggested by the registrant(s) under REACH",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,zinc pyrithione,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_133.pdf,,," < 2,000  to 10,000","LD50, mg/kg",,,,,,,,,,,,,,,,,ingredient-based study,,rabbit albino,,,,,,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,b66,,information on further acute dermal studies performed with zpt is available on ECHA's website (http://echa.europa.eu/). hse (2003) describes an acute dermal toxicity study  (limit study) performed in 5 male and 5 female new zealand white rabbits. the animals received a single dermal application of 2000 mg/kg zpt moistened with water which was held in place for 24 hrs under semi-occlusive patch. the LD50 was > 2000 mg/kg. a single death was noted but it was unclear whether this was treatment-related. ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,zinc pyrithione,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_133.pdf,,"no observable systemic effects in animals treated with 2.5, 5.0, or 10.0 g/kg. two of the four animals dosed with 20 g/kg showed a slight temporary depression. there were no deaths at any level.",,,,,these data are in line with a study on zpt alone indicating that its incorporation into a shampoo formulation does not significantly enhance penetration,,,,,,,,2,shampoo containing  zpt,,,,,"product derived,",,rabbit ,,,,,,,,,,"2.5, 5.0, 10.0, 20.0",g/kg,,,yes,,occluded with rubber sleeve,,,,,,,,,,24,,,,,,,,,"b61, b67",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,zinc pyrithione,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_133.pdf,,,36; 500,"LD50, mg/kg, in rats; in mouse",,,,,,,,,,,,,,,,,,,rat and mouse,,,,,,,,,,,,,,,,,,,,intraperitoneal ,,,,,,,,,,,,,,,"b71, b73",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,zinc pyrithione,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_133.pdf,,"generally, 25 mg/kg of zpt was fatal to both dogs and monkeys within 24 hours and produced cholinergic-like effects prior to death. doses of 15 and 20 mg/kg produced slight cholinergic stimulation in dogs but death did not result. one of two yorkshire pigs died when injected intravenously with 20 mg/kg and 10 mg/kg was a lethal dose for rabbits. intravenous doses of 5 mg/kg or less produced only transient effects. ",,,,,,,,,,,,,,,,,,,,,"dog, monkey, pig, rabbit",,,,,,,,,,,,,,,,,,,,intravenous,,,,,,,,,,,,,,,"b2, b7, b72",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,trisodium nitrilotriacetate,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_046.pdf,,,"750; 1300-1470, 1600-2220; >5000 ","LD50, mg/kg bw, monkey; female rat, male rat; dog",,,nta has a low acute toxicity by oral route,,,,,,,,,,,,,,,"monkeys, rats and dogs",,,,,,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,trisodium nitrilotriacetate,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_046.pdf,,,> 10, g/kg,,,nta has a low acute toxicity by dermal route,,,,,,,,25,aqueous substance solution,,,,,,rabbit,,,,,,,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,trisodium nitrilotriacetate,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_046.pdf,,,>5.0,LC50 in mg/l ,,,nta has a low acute toxicity by inhalation route,,,,,,,,,,,,,,,rats,,,,,,,,,,,,,,,,,,,yes,,,,,,,,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,vetiveryl acetate ,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_167.pdf,,the animals were observed for mortality/viability and changes in appearance and behaviour four times during test day 1 and once daily during days 2-15. body weights were recorded on test day 1 (pre-administration) and once daily during days 2-15.,>2000 ,"LD50, mg/kg bw",no,,"there were no deaths, clinical signs, macroscopic findings or affected body weight gain in any of the dosed animals",,,,,,,yellow liquid,,,,,9000317035,,ester content 65.9%,,rat / wistar,,,,f & m,,,,6,,2000, mg/kg bw,single,"yes, gavage",,,,,,,,10,,,polyethylene glycol (PEG 300),,,14,,"regarding the composition of the test substance it is mentioned in the original study report “not specified; excluded from the statement of compliance”, i.e. the composition of the test substance is unknown to the sccs.",1999,,yes,,,70,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,vetiveryl acetate ,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_167.pdf,,"observations for mortality were made at 1 and 6 hours after dosing and daily thereafter for 14 days. lethargy and diarrhoea, no findings from necroscopy",5000,mg/kg bw,"yes, two rats died within the first day after application",,the acute oral LD50 value was considered to be >5000 mg/kg bw in male wistar rats,,,,,,,brown liquid,,,,,,,"test substance: labelled ‘compound No. 71-90’, no information on ester content ",,rat / wistar,,m,,,,,fastened 16h prior to the administration,10,,5000,mg/kg bw,daily,yes,,,,,,,,,,,,,,14,,the study could not be evaluated by the sccs as the submitted original report only consisted of one page in addition to the front page. the composition of the test substance is unknown to the sccs.,1972,,no,,,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,vetiveryl acetate ,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_167.pdf,,"signs of skin irritation were noted during the course of the observation period in the form of slight to moderate erythema and oedema. both signs declined during the post treatment observation period but were still present for slight erythema in one animal at termination on day 7, while oedema was not observed from day 5 onwards.  no abnormalities were noted by gross pathology",>5000,"LD50, mg/kg bw",no,,,,,the acute dermal LD50 value was >5000 mg/kg bw in new zealand white rabbits.,,,,brown liquid,,,,,,,"test substance labelled ‘RIFM # 71-90’, no information on the ester content",,rabbit / new zealand white,,,,,,,,10,,5000,mg/kg bw,single,,yes,,occluded,,,,,,,,,,24,7,,the study could not be evaluated by the sccs as the submitted original report only consisted of two pages in addition to the front page. the composition of the test substance is unknown to the sccs.,1972,,no,,,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,vetiveryl acetate ,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_167.pdf,,"signs of stress in all animals after two hours of application, mice dosed at 2.0 recovered within 18 hours, and mice dosed at 5.0 ml/kg bw all recovered within 18 to 72 hours. both mice at the highest dosage group became ataxic after 18 hours, showed laboured breathing after 24 hours and died after 42 and 48 hours, respectively. the autopsy of the animals that died revealed bleaching of the stomach and small intestines, as well as pale/patchy liver with bleaching where in contact with the stomach, and pale kidneys. all surviving animals gained weight and appeared normal at autopsy",5.0 - 10.0,"LD50, between mentioned numbers in ml/kg bw",yes,"2 animals at 2mg/kg bw, 6 animals at 5 and 2 animals at 10",,,,,,,,yellow liquid,,,,,,,"named vetyvenyl acetate, no information on ester content",,mouse,,,,,,,fasted,,,"2, 5, 10",ml/kg bw,,"yes, intubation",,,,,,,,,,,,,,7,,the study could not be evaluated by the sccs as the submitted original report only consisted of two pages in addition to the front page. the composition of the test substance is unknown to the sccs.,,,,,,48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"toluene-2,5-diamine and its sulfate",non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_052.pdf,,"lethargy, piloerection, ataxia and increased salivation were observed shortly after dosing. at 100 mg/kg increased respiratory rate and above 100 mg/kg decreased respiratory rate were observed.  the acute median lethal oral dose and its 95% confidence limits were calculated to be 102 (69 – 152) mg/kg bw.",102,"LD50, mg/kg",yes,"lethality rate at dose 0, 0 in both sexes, at 64 mg/kg bw 3/5 in males and 0/5 in females; at 100, 4/5 in  males and 3/5 in females; at 160 0 in male and 5/5 in females and at the highest dose of 250, 5/5 in male and 4/5 in female",,,,,,,,,10,diluted in aqueoys sodium sulphite (0.05%),,,,,"test substance: toluene-2,5-diamine",,rat/cfy strain,,,,f & m,,,,10,,"0, 64, 100, 160, 250 ",mg/kg bw,single,"yes,  gavage",,,,,,,,,,,aqueous sodium sulphite,0.05,,14,,"despite the lack of data on the batch used and although the study does not conform to OECD guidelines, it is useful for evaluation.",,,no,,,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,sodium perborate  and perboric acid,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_031.pdf,,,"3250, 3600
male : 3600","LD50, mg/kg bw, female, male",,,,,,,,,,,,,,,,,test substance: sodium perborate(not specified),,mouse,,,,f & m,,,,,,,,,yes,,,,,,,,,,,,,,,,,2007,,,,,ecb 2007,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,sodium perborate  and perboric acid,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_031.pdf,,,1800,"LD50, mg/kg bw ",,,,,,,,,,,,,,,,,test substance: sodium perborate monohydrate,,rat,,,,,,,,,,,,,yes,,,,,,,,,,,,,,,,,1987,,,,,"interox, 1987a",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,sodium perborate  and perboric acid,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_031.pdf,,,2567,"LD50, mg/kg bw ",,,,,,,,,,,,,,,,,test substance: sodium perborate tetrahydrate,,rat,,,,,,,,,,,,,yes,,,,,,,,,,,,,,,,,1987,,,,,degussa 1987,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,sodium perborate  and perboric acid,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_031.pdf,,,100-500,"LD50, mg/kg bw ",,,,,,,,,,,,,,,,,"test substance: boric acid, sodium borate, or sodium perborate ",,human,,,,,,,,,,,,,yes,,,,,,,,,,,,,,,,,1987,,,,,"dreisbach, 1987",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,sodium perborate  and perboric acid,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_031.pdf,,,2000,"LD50, mg/kg bw ",yes, 1 male died after 13 days,,,,,,,,,,,,,,,test substance: sodium perborate monohydrate ,,rabbit,,,,,,,,,,,,,,yes,,,,,,,,,,,,,,,,1987,,,,,"interox, 1987b",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,sodium perborate  and perboric acid,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_031.pdf,,,1164,"LC50, mg/m3",,,,,,,,,,,,,,,,,test substance: sodium perborate tetrahydrate,,rat,,,,,,,,,,,,,,,,,,yes,,,,,,,,4,,,,2001,,,,,asta medica ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,resorcinol,OECD 420,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_015.pdf,,"observation once daily over the observation periof of 14 days, body weights recorded at dat 1 prior to treatment and on days 7 and 14 therefater. in the main experiment, no mortality occurred at 200 mg/kg bw. hypoactivity, dyspnoea and tremors were observed in all animals on day 1. recovery was complete on day 2. no effect on body weight gain and no gross abnormalities were observed. ",,,,,the maximal non-lethal dose of resorcinol was 200 mg/kg bw.,,,,,,,,,,98.8,,706030517,,,,rats/sprague-dawley rj:sd (iops han),,,,f,,,,4,,200, mg/kg bw,single oral dosing,"yes, gavage",,,,,,,,,,,,,,14,,,2004,,yes,"a preliminary study in three female rats at doses of 200, 500 and 2000mg/kg bw was performed prior to the principal study,. in this experiment, the animal treated at 2000 mg/kg bw died within 15 minutes of treatment; tonic-clonic convulsions were observed prior to death. at 500 mg/kg bw, death occurred within 20 minutes of treatment. piloerection and dyspnoea were observed within two hours of treatment at 200 mg/kg bw",,1,,guideline: fixed dose method,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"quinolinium, 4-formyl-1-methyl-, salt with 4-methylbenzene sulfonic acid (1:1)",OECD 423,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_080.pdf,,,> 2000,"LD50, mg/kg bw ",no,,during the observation period of 14 days no mortality and clinical-toxicological findings were seen. the body weights were within the normal range. no macroscopic findings were recorded at necropsy. the LD50 is greater than 2000 mg/kg bw.,,,,,,,,,,97.9,,Moe-HM-6116-190,,test substance: 4-formyl-1-methylquinolonium-p-toluenesulfonate in distilled water,,rat/ hanIbm:wist (spf),,,,f & m,,,,6,,2000, mg/kg bw,single,yes,,,,,,,,,,,bi-distilled water,,,14,,,,,yes,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"quinolinium, 4-formyl-1-methyl-, salt with 4-methylbenzene sulfonic acid (1:1)",OECD 402,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_080.pdf,,,> 2000,"LD50, mg/kg bw ",,,"the animals were examined for mortality, clinical signs and body weight. on day 15 the study was terminated and necropsy was performed. no treatment-related findings were observed. the LD50 is greater than 2000 mg/kg bw in this study.",,,,,,,,,,95.3,,Gro-HM-7733-092,,test substance: 4-formyl-1-methylquinolonium-p-toluenesulfonate in distilled water,,rat/wistar,,,,f & m,,,,10,,2000, mg/kg bw,single,,yes,on the back,semi-occluded,clipped ,,,,,,,deionised water,,24,14,,,,,yes,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,hydroxypropyl p-phenylenediamine and its dihydrochloride salt,non OECD ,https://ec.europa.eu/health/sites/health/files/scientific_committees/consumer_safety/docs/sccs_o_230.pdf,"lung, liver, general toxicity","lung and liver congestion were noted at necropsy. the clinical signs observed included lethargy, tremor, salivation, lacrimation, chromodacryorrhea and prostration in the high dose group. only mild salivation and lethargy were observed in the mid dose group. hydroxypropylp-phenylenediamine and its dihydrochloride salt were considered to be of moderate toxicity following single oral administration.",300 - 1000 ,"LD50, between the mentioned numbers mg/kg",yes,"mortality was obsereved in all rats (10/10) treated at 1000mg/kg at day 1,2or 3 post dosing. one death (1/10) was noted at the mild dose level of 300mg/kg/day at day 14 after dosing . ",the test chemical is moderately toxic after a single oral administration,,,,,,,,,,,,,,,,rat,,,,,,,,10,,"100, 300, 1000 ",mg/kg,single,"yes, gavage",,,,,,,,,,,,,,14,,the 14-day oral repeated dose toxicity study provides evidence that hydroxypropyl pphenylenediamine 2HCl caused mortality at dose levels of 300 and 1000 mg/kg. this study indicates that the LD50 is above 300 mg/kg.,,,no,,,"mehta,2013",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,polysilicone-15,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_024.pdf,,"clinical signs were observed on 3 occasions on the first day of the experiment, and daily thereafter (except weekends). body weights were recorded every 3 days. following sacrifice, the animals were subjected to necropsy.no deaths occurred. no clinical abnormalities were observed. weight gain of the animals was what would be expected of this strain. no abnormalities were found at autopsy.",> 2000,"LD50,  mg/kg bw",no,,greater than 2000 mg/kg bw,,,,,,,,,,,,,,,,rat/wistar spf,,,,f & m,,,animals  had been fasted for 17 hours,10,,2000, mg/kg bw,single,"yes, gavage",,,,,,,, 5,,,sodium carboxymethylcellulose,0.5,,14,,,,,yes ,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,polysilicone-15,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_024.pdf,,"no deaths, and no clinical abnormalities, no skin lesions were seen. increase in body weight was what would be expected in this strain of animal. necropsy was normal.",> 2001,"LD50, mg/kg bw",no,,greater than 2000 mg/kg bw,,,,,,,,,,,,,,,,rat/wistar spf,,,,f & m,,,,10,,,pure active substance was applied,single/24h,,yes,"backs and flanks (16 cm²,about 10% of the body surface)",occlusive dressing,"intact, shaved with an electric clipper ",,,,,"after removing the patch, the area was washed off with ethanol 70% in warm water ",,,,24,14,,,,,yes ,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,polysilicone-15,OECD 430,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_024.pdf,lungs,"mortality and clinical signs were checked on the day of exposure, and twice (mortality) or once (clinical signs) days until day 15. body weight was recorded on day 0, 4, 8 and 15. necropsy was performed on the day that the animals were found dead or on day 15.there were no clinical signs during or after the inhalation exposure in group 1. in group 2, clinical signs were only seen from the day after the exposure. the clinical signs consisted of restlessness and ruffled fur, both findings slight to marked in degree, and of tachypnea and hunched posture and were followed by premature death or had cleared within 3 to 5 days in the one survivor of this group. this survivor remained free from clinical signs from five days after exposure onwards. there were no relevant, adverse effects on body weight development in the survivors of groups 1 and 2. necropsy did not reveal any macroscopic pathology changes in any of the survivors either of group 1 or group 2. in the two decedents of group 1 the lungs were dark red discoloured and incompletely collapsed, and in the nine decedents of group 2 the lungs were dark red discoloured. ",,,yes," in group 1, two of ten animals were found dead on the day after the exposure. in group 2 nine of ten animals were found dead, one or two days after exposure.","no LC50 of Parsol SLX was calculated from this study, but was estimated to be between 0.285 and 1.838 mg/l air.",,,,,,,,,,,,,"at ambient temperature, the test substance was too viscous for aerosol generation. therefore, the test material was to a temperature of 55°C prior to nebulisation. two gravimetric measurements of particle size distribution produced mass median aerodynamic diameters (MMAD) and geometric standard deviations (GSD) of 2.64 µm (GSD 2.63) and 3.03 µm (GSD 2.49) for group 1, and 2.67 µm (GSD 2.74) and 2.66 µm (GSD 2.73) for group 2. ",test material was to a temperature of 55°C prior to nebulisation,,rat/hanwistar,,,,f & m,,,,10,,0.285 (group 1) and 1.838 mg/l air(group 2) ,mg/l ,"single, flow-past inhalation chamber ",,,,,,"yes, nose-only ",,,,,,,,4,15,,,,,yes,,,"9 (subm. 2), 12 (subm. 2)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,picramic acid and sodium picramate,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_042.pdf,"liver, kidney, spleen ","signs of reactions to treatment were observed shortly after dosing, including lethargy, piloerection and orange staining of external extremities. these signs were accompanied within five hours by gasping in six rats treated at 100 mg/kg bw. death occurred from within one to 19 hours of treatment. autopsy revealed discoloration of the liver, pallor of the kidneys and spleen, and orange staining of the inner body wall. recovery of survivors, as judged by external appearance and behaviour was apparently complete within five days after treatment. bodyweight gains were within normal limits compared with controls and normal autopsy findings.",110,"LD50, mg/kg bw",yes,death occurred from within one to 19 hours of treatment.,the acute median lethal oral dose (LD50) and its 95% confidence limits to rats of picramic acid were calculated to be 110 (63-176) mg/kg bw.,,,,,,,,,,,,,,test substance: picramic acid,,rat/cfy,,,,f & m,,,starved overnight before treatment,10,,"0, 100, 160, 250, 400 and 640",ml/kg bw,,"yes,  intubation",,,,,,,,1.0 to 6.4 ,,,10 % suspension in aqueous gum tragacanth (0.5%)  containing sodium sulfite0.05%,10 / 0.5 / 0.05,,14,,,1976,,no,"the results of preliminary range finding tests indicated that the median lethal oral dose  (LD50), was in the region of 100 to 400 mg/kg bw. ",,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,phenylene bis-diphenyltriazine,OECD TG 423,https://ec.europa.eu/health/sites/health/files/scientific_committees/consumer_safety/docs/sccs_o_215.pdf,,"parameters evaluated included mortality and clinical signs which were recorded twice daily. body weights were measured on days 1, 3, 8 and 15 and necropsy findings noted for all animals on day 15. ",> 2500 mg/kg bw,"LD50, mg/kg bw",no,,"no mortality occurred and no abnormal clinical signs were observed at either dose level. body weight gain was not affected by treatment. no abnormal findings were noted in the macroscopic examination. within the experimental conditions of the study, WP30 led to no mortality. the LD50 was estimated to be higher than 2500 mg/kg bw for female wistar rats.",,,,,,,fine yellow powder,,,99.6,,LP110,,test substance: wp30,,rat/wistar rjhan: wi,,8-12 ,w,f,,,,3,,"300, 2000",mg/kg,"single in a stepwise procedure with a maximum of 2 steps per dose-level; each step using 3 animals. the starting dose was fixed at 300 mg/kg; 2000 mg/kg was then tested in the absence of mortality at 300 mg/kg. for both dose levels, two steps were performed. ","yes, gavage",,,,,,,,10,,,"corn oil (sigma-Aldrich, ref.C8267, batch 098K0008, expiry date: 28/05/2014)",,,14,,,2009,,yes,,,32 (submission 2),,23 animals  in total,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,phenylene bis-diphenyltriazine,OECD TG 404 and 402,https://ec.europa.eu/health/sites/health/files/scientific_committees/consumer_safety/docs/sccs_o_215.pdf,,"animals were observed at least once daily for mortality and general clinical signs for 15 days and were weighed on d1, d3, d8 and d15. skin reactions were evaluated for all animals approximately 1 hour (d2), 24h (d3), 48h (d4) and 72h (d5) after patch removal at the end of the contact period and on d8 and d11. ",> 2000 mg/kg bw,"LD50, mg/kg bw",no,,"no death occurred during the course of the study and no abnormal clinical signs were observed. body weight: for males, body weight evolution was not affected by the treatment. for females, the treatment induced a slight body weight loss (-2 grams in average) observed in all females between D1 and D3 but weight increase was restored thereafter. this transient observation on body weight evolution was most probably related to the nonocclusive tape. skin reaction: neither erythema nor edema was observed so that the individual irritation index was equal to 0 for all animals. consequently, the primary irritation index of the group was also equal to 0. desquamation was present on D5 (72 h reading time) in one female and on D8 in 2 females. within the experimental conditions of the study, the potential acute dermal toxicity of WP30 was evaluated after a single topical application on wistar rat skin. 5 males and 5 females were treated at 2000 mg/kg bw in a limit test for a 24-hour exposure period. no mortality was observed and the LD50 by dermal application was estimated to be higher than 2000 mg/kg bw. furthermore, WP30 was not irritating to the skin of rats.",,"the responses, erythema and edema, were scored according to a table graded from 0 (no skin reaction) up to 4 (severe reaction). ",,,,,,,,99.6,,LP110,,test substance: wp30,,rat/wistar rjhan: wi SPF albino rats,,,,f & m,,,,10,,2000,mg/kg,single,,yes,10% of the body surface,gauze patch held in close contact with the skin by means of a non-occlusive tape,dorsal part of the trunk (clipped the day before) ,,,,10,"after the exposure time, the patch was removed and the test site was wiped with a cotton pad soaked with purified water.",,purified water,,24,15,,,2011,,yes,,,35 (submission 2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,phenylene bis-diphenyltriazine,non OECD,https://ec.europa.eu/health/sites/health/files/scientific_committees/consumer_safety/docs/sccs_o_215.pdf,,"no overt signs of toxicity were observed under these study conditions. the LOAEC is 0.63 mg/L and the LOAEL calculated from the inhalation exposure is 115 mg/kg bw/day for the test item, corresponding to 0.29 mg/L and 54 mg/kg bw/day for the ground active substance. a NOAEC or NOAEL value cannot be derived from this study due to the serious effects observed in the respiratory tract, possibly due to a particle overload effect of the test item particles that are barely soluble and persistent. no safe concentration for the use in spray applications can be derived. the concentrations/doses for the repeated-dose inhalation study derived from the acute inhalation toxicity study (used as a pilot study) were too high. 

",,,,,,,,,,,,,"concentrations corresponding to 0, 0.29, 0.55 and 0.98 mg/L for the ground active substance",,,,,,test substance: cosmetic ingredient S02771,,rat,,,,f & m,,,,2,," 0, 0,63, 1.21, 2.13",achieved aerosol concentration of the suspension in mg/L ,,,,,,,"yes, nose-only",,,,,,,,"1, 2, 4 (acute toxicity) ; 14-day exposure, 4 hours per day (repeated dose)",14,,the study results suggest low acute inhalation toxicity of the test item.,,no control group was reported.,no,,,85 (submission 1),,"the dates of the in-life phase of the study were partly after the date of the animal testing ban of 13 March 2013. in a letter dated 4 march 2015, the applicant argues that the study was performed to comply not only with european but also with other international regulations. furthermore it was claimed that the substance was considered to be used as a new pharmaceutical ingredient and that the study also had to be conducted for deriving concentration limits of the substance at work places.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,methylimidazoliumpropyl p-phenylenediamine HCl ,OECD 401,https://ec.europa.eu/health/sites/health/files/scientific_committees/consumer_safety/docs/sccs_o_231.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"animals were observed at least daily for clinical signs and twice daily for mortality. body weights were recorded on day 1 just before treatment and on days 5 and 8. animals found dead or killed prematurely and all surviving animals killed at the end of the study were subjected to macroscopic examination. organs showing gross anomalies were sampled and preserved, but no histopathological examination was performed. neither mortality nor clinical signs were observed during the study.",, microscopic examination of the main organs of the animals revealed no apparent abnormalities.,"animals were observed at least daily for clinical signs and twice daily for mortality. body weights were recorded on day 1 just before treatment and on days 5 and 8. animals found dead or killed prematurely and all surviving animals killed at the end of the study were subjected to macroscopic examination. organs showing gross anomalies were sampled and preserved, but no histopathological examination was performed. neither mortality nor clinical signs were observed during the study.",, microscopic examination of the main organs of the animals revealed no apparent abnormalities.,> 500,,,,no,,no,,"under the conditions of this study, no clinical signs and no deaths were observed after a single oral administration of methylimidazoliumpropyl p-phenylenediamine, Cl, 2HCl (A166) at the dose level of 500 mg/kg in rats.",,,,,,,,rf006,test substance: c16778,,rat/sprague-dawley,,,,,,,,f &m ,fasted overnight,6,,500,mg/kg,10,single,gavage,purified water,,8,,"animals were observed until day 8 instead of for 14 days, but since no mortality was registered, it can be deduced that the oral LD50 is higher than 500 mg/kg b.w",1997,,yes,,1,de jouffrey s (1997),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,p-aminophenol,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_078.pdf,,,"671, 1270","LD50, mg/kg bw",,,,,,,,,,,,,,,,,,,rat,,,,,,,,,,,,,yes,,,,,,,,,,,,,,,,,1977,,,,,c26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,p-aminophenol,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_078.pdf,,,375,"LD50, mg/kg bw",,,,,,,,,,,,,,,,,,,rat,,,,,,,,,,,,,yes,,,,,,,,,,,,,,,,,1975,,,,,c23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,p-aminophenol,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_078.pdf,,,1550,"LD50, mg/kg bw",,,,,,,,,,,,,,,,,,,mice,,,,,,,,,,,,,yes,,,,,,,,,,,,,,,,,1977,,,,,c43,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,p-aminophenol,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_078.pdf,,,"393, 1139; 4-10","LD50, mg/kg bw in rat male, female; rabbit between metioned numbers g/kg bw",,,,,,,,,,,,,,,,,,,rat and rabbit,,,,f & m,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,,a2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,p-aminophenol,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_078.pdf,, methaemoglobin concentration was less than 10% of the total haemoglobin concentration., 0.5,"LD50, g/kg bw ",yes,deaths were reported within 48 hours of compound administration.,,,,,,,,,5,suspension,,,,,,,rat albino,,,,,,,,,,,,,yes,,,,,,,,,,,starch solution,3,,,,,,,,,,a1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,p-aminophenol,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_078.pdf,,,37,"LD50, mg/kg bw",,,,,,,,,,,,,,,,,,,cat,,,,,,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,c29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,p-aminophenol,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_078.pdf,,,470,"LD50, mg/kg bw",,,,,,,,,,,,,,,,,,,mouse,,,,,,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,a2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,p-aminophenol,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_078.pdf,,,10000,"LD50, mg/kg bw",,,,,,,,,,,,,,,,,,,rabbit,,,,,,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,c23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,p-aminophenol,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_078.pdf,,,>8000; >5000,"LD50, mg/kg bw in rabbit; in rat",,,,,,,,,,,,,,,,,,,rabbit and rat,,,,,,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,a2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,p-aminophenol,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_078.pdf,,,>0.005,"LC50, mg/l",,,,,,,,,,,,,,,,,,,rat,,,,,,,,,,,,,,,,,,yes,,,,,,,,1,,,,,,,,,c23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,p-aminophenol,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_078.pdf,,," >5.91,  >3.42","LC50, mg/l in 1.3 hour exposure; 4 hour exposure",,,,,,,,,,,,,,,,,,,rat,,,,,,,,,,,,,,,,,,yes,,,,,,,,"1.3,  4 ",,,,,,,,,a2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,n-methyl-2-pyrrolidone (NMP),non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_050.pdf,,,4150 (3100-5560),"LD50, mg/kg bw ",,,,,,,,,,,,,,,,,,,rat,,,,,,,,,,,,,yes,,,,,,,,,,,,,,,,nmp has low acute toxicity by oral route,,,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,n-methyl-2-pyrrolidone (NMP),non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_050.pdf,,,3906 (3100-4400),"LD50, mg/kg bw ",,,,,,,,,,,,,,,,,,,rat,,,,,,,,,,,,,yes,,,,,,,,,,,,,,,,nmp has low acute toxicity by oral route,,,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,n-methyl-2-pyrrolidone (NMP),non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_050.pdf,,,7710 (5900-9600),"LD50, mg/kg bw ",,,,,,,,,,,,,,,,,,,mouse,,,,,,,,,,,,,yes,,,,,,,,,,,,,,,,nmp has low acute toxicity by oral route,,,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,n-methyl-2-pyrrolidone (NMP),non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_050.pdf,,,2500 - 5000,"LD50, mg/kg bw ",,,,,,,,,,,,,,,,,,,rat,,,,,,,,,,,,,,yes,,,,,,,,,,,,,,,nmp has low acute toxicity by dermal route,,,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,n-methyl-2-pyrrolidone (NMP),non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_050.pdf,,,˃ 5.1,LC50 mg/l ,,,,,,,,,,,,,,,,87% of aerosol particles< 8.5 µm,,,rat,,,,,,,,,,,,,,,,,,"yes, head only",,,,,,,,4,,,nmp has low acute toxicity by inhalation route,2000,,,,,IUCLID dataset,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,hc yellow n° 4,OECD 401,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_008.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"during the observation period of 14 days, a record was kept for mortalities and signs of toxicity. body weights were recorded on day 0 and day 14 for the surviving animals. all rats that died were investigated macroscopically to identify organ changes in the skull, thorax and abdomen and surviving animals were similarly examined at the end of the 14- day post-observation.",,,"during the observation period of 14 days, a record was kept for mortalities and signs of toxicity. body weights were recorded on day 0 and day 14 for the surviving animals. all rats that died were investigated macroscopically to identify organ changes in the skull, thorax and abdomen and surviving animals were similarly examined at the end of the 14- day post-observation.",,,> 5000,,,,no,,no,,no mortalities occurred at the dose of 5 g/kg bw. yellow colorations of the skin and mucosae were observed until the fourth day after administration of the tested dose. no other signs of reaction to treatment were observed.,,,,50,aqueous suspension,,,,,,rat /bor: wisw spf tno,,,,,193-209 , 155-193,g,f&m,starved 16h before treatment,10,,5000, mg/kg bw,,,intubation,distilled water,,14,,,1985,,no,"hc yellow n°4 was prepared as a 50 % suspension in distilled water and administered by oral intubation at the doses of 1, 2.5 and 5 g/kg bw in range finding test (2 males per dose). as no mortalities occurred at these doses, 5 g/kg bw was chosen for the primary test (5 males and 5 females). ",3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,hc yellow n° 4,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_008.pdf,,,"1250-5000, 1250-2500 ","LD50, mg/kg bw  between mentioned numbers in male, in female",,,"the results of this study indicated that the median lethal oral dose (LD5O), was in the region of 1250 to 5000 mg/kg bw in the male rats and in the region of 1250 and 2500 mg/kg bw in females. dosing was then extended to larger groups of rats (five males and five females) in order to set the median lethal dose more precisely. signs of reaction to treatment were not recorded.",,,,,,,,10,,,,,,,,rat/sprague-dawley,,,,f&m,190 -240 ,g,,5,,"1250, 5000; 1250, 2500, 5000", mg/kg bw in males; in females,,"yes, gavage",,,,,,,,,,,acacia in water,3,,14,,,1987,,no,,,3,,the experiment did not conform to a guideline and the experimental description is incomplete. ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,hc yellow n° 4,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_008.pdf,"5 male and 5 female rats were treated at the dose of 2000 mg/kg bw. as this dose produced mortality, a further group of 5 male and 5 female rats were treated at the dose of 500 mg/kg bw. rats were weighed prior to dosing (day 0), day 7 and day 14. during the observation period of 14 days, a record was kept of mortalities and signs of toxicity. all rats that died were examined macroscopically to identify organs changes and surviving animals were similarly examined. the dose of 2000 mg/kg bw produced mortality in 4 male and 4 female rats. signs of piloerection, soiled coat, reduced activity, ataxia, subdued behaviour, prostration, hunched appearance and laboured breathing were observed for all animals in day of dosing. most of these signs were also observed in the 2 surviving rats at day 5 after dosing. yellow colorations of urines and extremities were observed in all animals after dosing. these colorations were also observed in surviving rats after the end of the 14 days observation period. Yellow colorations of stomach, intestines, skin, coat and tail were observed. the dose of 500 mg/kg bw produced no mortality in male and female rats. signs of piloerection, reduced activity and hunched appearance were observed for all animals from the day of dosing until 5 days after dosing. yellow colorations of urines and extremities were observed in all animals after dosing. these colorations were also observed after the end of the 14 days observation period. No other effects were observed at this dose.",,>500,"LD50, mg/kg bw ",yes, 8 died at 2000mg/kg bw ,"under the conditions of the study, hc yellow n°4 is considered as having acute oral toxicity above 500 mg/kg/bw.",,,,,,,,,suspension in vehicle,,,930700805,,,,rat/sprague-dawley,,,,f&m,127 - 186 ,g,starved overnight before treatment,10,,"2000, 500", mg/kg bw,,"yes, gavage",,,,,,,,10,,,aqueous carboxymethylcellulose,0.5,,14,,,1994,,yes,,,4,,"guideline: acute oral toxicity test (fixed dose procedure) EC Directive 84/449/EEC Annex V, test B1. ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,hydroxyethyl-2-nitro-p-toluidine,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_061.pdf,"the animals were checked daily for clinical signs and deaths. body weights were recorded on study day 1, day 7 and day 14. post-mortems of all animals were conducted. hydroxyethyl-2-nitro-p-toluidine caused reduced activity and orange coloration of the urine and extremities. both effects had disappeared after 24 h. no overt signs of toxicity were observed in survivors. body weight increased at all doses. no post-mortem changes were noted. ",,"1564, 1436; 1600, 1750 ","LD50, mg/kg bw in rat male, female; mouse male, female",yes,", mortalities occurred within 24h of administering the test substance. rat  at dose mg/kg bw 900: male 2/6, female 1/6; at dose 1700: male 3/6, female 3/6; at dose 2500: male 6/6, female 6/6. mouse at dose mg/kg bw 1000: male 2/10, female 0/10; at dose 1500: male 4/10, female 4/10; at dose 2000: male 7/10, female 6/10; at dose 2500: male 10/10, female 10/10. ","though this study does not follow guideline 401, (1981), the results indicate that the acute oral toxicity of hydroxyethyl-2-nitro-p-toluidine is low.",,,,,,,,,,99.6,,bra1/285,,,,rat/ wistar; mouse/cf1,,,,f&m,,,,12 / 20,,"900, 1700, 2500; 1000, 1500, 2000, 2500",mg/kg bw in rats; in mice,single,"yes,  gavage",,,,,,,,,,,gum arabic solution,10,,14,,the dose range was determined by a preliminary mouse study that indicated a median lethal dose between 1000 and 2000 mg/kg bw. ,1985,,no,the dose range was determined by a preliminary mouse study that indicated a median lethal dose between 1000 and 2000 mg/kg bw. ,,"13, submission 3",,"the protocol did not follow oecd guideline 401, but is described as ‘in analogy to appraisal of the safety of chemicals in foods, drugs and cosmetics’. a quality assurance statement, dated 12 September 1991, was included. ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,hydroxyethyl-2-nitro-p-toluidine,OECD 402,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_061.pdf,body weight depression,"clinical observations were made for 1, 10, and 30 min, 1, 2, 4, 6 hours and then at least twice daily for 14 days.  body weights were recorded on study day 1, day 7 and day 14. post-mortems of all animals were conducted. three animals of each sex displayed signs of general malaise (chromodacryorrhoea and ruffled fur) during the first 2 days.  body weight gain decreased in female rats over the 14 days ",> 2000,"LD50, mg/kg bw",no,,,,,,,,,,,,99.8,,B 3/89 ,,,,rat/sprague dawley him: ofa spf,,,,f&m,,,,10,,2000, mg/kg bw,,,yes,30cm2,covered with tape,clipped skin,,,,,after the exposure time the test substance was wiped off.,,,,24,,,,1990,,yes,,,"14, submission 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"o-phenylphenol, sodium o-phenylphenate and potassium o-phenylphenate",non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_177.pdf,,,≈ 3000,"LD50, mg/kg bw",,,,,,,,,,,,,,,,,test substance: OPP,,rat,,,,,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,,154,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"o-phenylphenol, sodium o-phenylphenate and potassium o-phenylphenate",non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_177.pdf,,,≈ 2700,"LD50,mg/kg bw",,,,,,,,,,,,,,,,,test substance: OPP,,rat,,,,m,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,,105,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"o-phenylphenol, sodium o-phenylphenate and potassium o-phenylphenate",non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_177.pdf,,,2980,"LD50, mg/kg bw",,,,,,,,,,,,,,,,,test substance: OPP,,rat,,,,m,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,,150,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"o-phenylphenol, sodium o-phenylphenate and potassium o-phenylphenate",non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_177.pdf,,,"2600, 2850 ","LD50, mg/kg bw in male, female",,,,,,,,,,,,,,,,,test substance: OPP,,rat,,,,f & m,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,,278,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"o-phenylphenol, sodium o-phenylphenate and potassium o-phenylphenate",non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_177.pdf,,,"2850, 3600","LD50, mg/kg bw in male, female",,,,,,,,,,,,,,,,,test substance: OPP,,rat,,,,f & m,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,,98,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"o-phenylphenol, sodium o-phenylphenate and potassium o-phenylphenate",non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_177.pdf,,,2733,"LD50, mg/kg bw",,,,,,,,,,,,,,,,,test substance: OPP,,rat,,,,f & m,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,,77,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"o-phenylphenol, sodium o-phenylphenate and potassium o-phenylphenate",non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_177.pdf,,,≈ 2000,"LD50, mg/kg bw",,,,,,,,,,,,,,,,,test substance: OPP,,mouse,,,,,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,,313,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"o-phenylphenol, sodium o-phenylphenate and potassium o-phenylphenate",non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_177.pdf,,,"≈ 1200, ≈ 1050","LD50, mg/kg bw in male, female",,,,,,,,,,,,,,,,,test substance: OPP,,mouse,,,,f & m,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,,275,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"o-phenylphenol, sodium o-phenylphenate and potassium o-phenylphenate",non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_177.pdf,,,"3499, 3152","LD50, mg/kg bw in male, female",,,,,,,,,,,,,,,,,test substance: OPP,,mouse,,,,f & m,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,,280,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"o-phenylphenol, sodium o-phenylphenate and potassium o-phenylphenate",non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_177.pdf,,,≈ 500,"LD50, mg/kg bw",,,,,,,,,,,,,,,,,test substance: OPP,,cat,,,,,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,,154,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"o-phenylphenol, sodium o-phenylphenate and potassium o-phenylphenate",non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_177.pdf,,,1250,"LD50, mg/kg bw",,,,,,,,,,,,,,,,,test substance: SOPP,,rat,,,,,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,,85,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"o-phenylphenol, sodium o-phenylphenate and potassium o-phenylphenate",non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_177.pdf,,,"1650, 1550","LD50, mg/kg bw in male, female",,,,,,,,,,,,,,,,,test substance: SOPP,,rat,,,,f & m,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,,276,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"o-phenylphenol, sodium o-phenylphenate and potassium o-phenylphenate",non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_177.pdf,,,1096,"LD50, mg/kg bw",,,,,,,,,,,,,,,,,test substance: SOPP,,rat,,,,f & m,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,,279,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"o-phenylphenol, sodium o-phenylphenate and potassium o-phenylphenate",non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_177.pdf,,,"846, 591","LD50, mg/kg bw in male, female",,,,,,,,,,,,,,,,,test substance: SOPP,,rat,,,,f & m,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,,78,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"o-phenylphenol, sodium o-phenylphenate and potassium o-phenylphenate",non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_177.pdf,,,"857, 812 / 1018, 683 ","LD50, mg/kg bw in male, female / in male, female",,,,,,,,,,,,,,,,,test substance: SOPP produced by DOW chemicals / SOPP produced by Tokyo Kasei Co,,mouse,,,,f & m,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,,206,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"o-phenylphenol, sodium o-phenylphenate and potassium o-phenylphenate",non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_177.pdf,,,"2573, 2118","LD50, mg/kg bw in male, female",,,,,,,,,,,,,,,,,test substance: POPP,,rat,,,,f & m,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,,14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"o-phenylphenol, sodium o-phenylphenate and potassium o-phenylphenate",non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_177.pdf,,,> 2000,"LD50, mg/kg bw",,,,,,,,,,,,,,,,,test substance: OPP,,rat,,,,f & m,,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"o-phenylphenol, sodium o-phenylphenate and potassium o-phenylphenate",non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_177.pdf,,,> 5000,"LD50, mg/kg bw",,,,,,,,,,,,,,,,,test substance: OPP,,rabbit,,,,f & m,,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"o-phenylphenol, sodium o-phenylphenate and potassium o-phenylphenate",non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_177.pdf,,,> 2000,"LD50, mg/kg bw",,,,,,,,,,,,,,,,,test substance: POPP,,rat,,,,f & m,,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"o-phenylphenol, sodium o-phenylphenate and potassium o-phenylphenate",non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_177.pdf,,, > 949,LC50 mg/m3,,,,,,,,,,,,,,,,aerosol,test substance: OPP,,rat,,,,m,,,,,,,,,,,,,yes,,,,,,,,,1,,,,,,,,,161,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"o-phenylphenol, sodium o-phenylphenate and potassium o-phenylphenate",non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_177.pdf,,,> 36,LC50 mg/m3,,,,,,,,,,,,,,,,vapour,test substance: OPP,,rat,,,,f & m,,,,,,,,,,,,,yes,,,,,,,,,4,,,,,,,,,149,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"o-phenylphenol, sodium o-phenylphenate and potassium o-phenylphenate",non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_177.pdf,,,> 1331,LC50 mg/m3,,,,,,,,,,,,,,,,aerosol,test substance: SOPP,,rat,,,,m,,,,,,,,,,,,,yes,,,,,,,water,,1,,,,,,,,,161,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,o-aminophenol,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_025.pdf,,,1.052,"LD50, mg/kg bw",,,,,,,,,,,,,,,,,test substance: 1-hydroxy-2-aminobenzene,,rat/ofa,,,,f & m,,,,10,,"500, 1000, 1250, 2000, 2500", mg/kg bw,,,,,,,,,,,,,carboxymethylcellulose,1,,,,,,,,,,1 (subm. 1),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,o-aminophenol,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_025.pdf,,"methaemoglobin concentration was less than 10% of all haemoglobin. death occurred within 1 to 48 hours of dosing and calculation gave a median lethal dose of 1,300 mg/kg bw.",1.3,"LD50, mg/kg bw",yes,,,,,,,,,,5, suspension ,,,,,,,rat,,,,,,,,,,,,,yes,,,,,,,,,,,starch solution,3,,,,,,,,,,1-5 (subm. 5),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,o-aminophenol,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_025.pdf,,,1.259,"LD50, mg/kg bw",,,,,,,,,,,,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2,4,6 (subm. 5)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"n,n’-bis-(2-hydroxyethyl)-2-nitro-p-phenylenediamine",non OECD,https://ec.europa.eu/health/sites/health/files/scientific_committees/consumer_safety/docs/sccs_o_196.pdf,,"skin and mucosa showed discolouration, no clinical signs were observed and the weight gain was normal.",,,no,,,,,,,,,,50,suspension,,,,,,,rat/bor: wisw wistar,,,,f & m,,,,10,,5,g/kg bw,single,"yes, gavage",,,,,,,,,,,distilled water,,,,,,,,,"in a dose-range finding study, 2 females per dose group were treated with 1, 2.5 and 5 g/kg bw of the test substance and no mortalities were observed.",,"3, submission 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,methoxypropylamino cyclohexenylidene ethoxyethylcyanoacetate (S87),non OECD,https://ec.europa.eu/health/sites/health/files/scientific_committees/consumer_safety/docs/sccs_o_227.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,hydroxyethyl-p-phenylenediamine sulfate ,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_017.pdf,,"20 minutes after administration, the test compound caused moderate sedation and ataxia. no changes were observed in organs. ",150; 90 ,"LD50, mg/kg bw in rat; mouse",,,the substance was considered to be moderately toxic.,,,,,,,,1.0,aqueous solution,,,,,test substance: hydroxyethyl-p-phenylenediamine dihydrochloride ,,"rat/wistar (spf), mice/cf1 (spf) ",,,,rats: f & m / mice: f,≈ 187 ; ≈194 / ≈ 26,"gram, 25 female;  25 male wistar rats / 50 female cf1 mice ",,10,,"50, 100, 200, 300, 400;  50, 100, 150",mg/kg bw/day in rat; in mouse,single,"yes, gavage",,,,,,,,,,,,,,14,,the experiment was not performed in compliance with guidelines. it was performed with the dihydrochloride instead of the sulfate salt.,,,no,,,17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,hydroxyethyl-p-phenylenediamine sulfate ,OECD 401,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_017.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"behaviour, reactions and physical signs of the animals were observed and findings were recorded at 1, 10, 30 min, 1, 2, 4 and 6 hours post administration and then at least once a day for 2 weeks. body weight was determined before administration, and 7 and 14 days post administration. any found dead animal was dissected and submitted to a macroscopic post-mortem examination in order to identify the target organs. all surviving animals were sacrificed by CO2 asphyxation at 14 days post administration and examined macroscopically. no effects on body weight and body weight gain were observed. all animals showed signs of malaise (e.g. decreased motor activity, ruffled fur, closed eyes, hunched posture, decreased muscular tension or unconsciousness). in some animals ataxia, dyspnoea or low grade convulsions were observed. fffects diminished and returned to normal within 6hr – 1wk post administration.",7/20 of the animals that died early did not show any clinical signs at the post-mortem examination. most of the other animals that died early showed signs of shock due to severe gastrointestinal irritations or hepatotoxicity,,"behaviour, reactions and physical signs of the animals were observed and findings were recorded at 1, 10, 30 min, 1, 2, 4 and 6 hours post administration and then at least once a day for 2 weeks. body weight was determined before administration, and 7 and 14 days post administration. any found dead animal was dissected and submitted to a macroscopic post-mortem examination in order to identify the target organs. all surviving animals were sacrificed by CO2 asphyxation at 14 days post administration and examined macroscopically. no effects on body weight and body weight gain were observed. all animals showed signs of malaise (e.g. decreased motor activity, ruffled fur, closed eyes, hunched posture, decreased muscular tension or unconsciousness). in some animals ataxia, dyspnoea or low grade convulsions were observed. fffects diminished and returned to normal within 6hr – 1wk post administration.",7/20 of the animals that died early did not show any clinical signs at the post-mortem examination. most of the other animals that died early showed signs of shock due to severe gastrointestinal irritations or hepatotoxicity,,80,71-89,,,yes,all dead in the 112 or 200mg/kg bw. death occurred between 1 hr-4 days in the 112 mg/kg bw group and between 30 min-2 hr in the 200 mg/kg bw group. 1/10 of the animals in the 63 mg/kg bw died within 4 hr post administration. ,yes,all dead in the 112 or 200mg/kg bw. death occurred between 1 hr-4 days in the 112 mg/kg bw group and between 30 min-2 hr in the 200 mg/kg bw group. 1/10 of the animals in the 63 mg/kg bw died within 4 hr post administration. ,"under the experimental conditions of this study, the LD50 was 80 mg/kg bw (71-89 mg/kg bw 95% CI), calculated for both sexes combined.",,,,,test substance dissolved in distilled water ,> 98,,,"test substance: hydroxyethyl-p-phenylenediamine (1,4-diamino-2-ßhydroxyethylbenzene-sulfate)",,mouse/him:ofi,,,,,,,,f & m,,10,,"20, 36, 63, 112, 200 ",mg/kg bw,,single ( in the morning),gavage,,,14,,,1990,,yes,"the dosage-range was based on a preliminary study, in which all animals (4/4) died after receiving 200 or 2000 mg/kg bw hydroxyethyl-p-phenylenediamine. ",2,18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,hc yellow n°9,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_026.pdf,,"the animals were observed daily for 14 days after dosing. body weights were recorded on days 1, 8 and 15 of the study. macroscopic examination of main organs was performed at autopsy. no histological examinations were performed. results:  at autopsy congestion and oedema of the lungs and oedema of the peritoneal cavity were reported in rats dying during the study period. no abnormalities were detected in animals sacrificed on day 14. ","745, 1609 ","LD50, mg/kg bw in male, female",yes,"mortalities occurred in all dose groups within 1 hour of treatment. numbers of deaths were 2, 4, 5, 5, 5 males and 1, 1, 1, 3, 3 females at 700, 910, 1180, 1540 and 2000 mg/kg bw, respectively",,,,,,,,,,test substance suspension in 1% aqueous cmc,,,dg1,,test substance: hc yellow n° 9 suspended in 1.0% aqueous carboxymethylcellulose,,rat/sprague dawley ofa (spf),,,,f & m,,,,10,,"700, 910, 1180, 1540, 2000",mg/kg bw ,single,"yes, gastric gavage",,,,,,,,,,,aqueous carboxymethylcellulose,1.0,,14,,,,,no,,,1 (subm. 2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,hc yellow n°9,OECD 420,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_026.pdf,general malaise,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,yes,"in the sighting test, the test item was administered by oral route (gavage) at the dose level of 500 or 2000 mg/kg to one female per dose level (1 animal per group). result: at the dose level of 500 mg/kg, no mortality was observed, and the female showed hypoactivity, piloerection and dyspnea on day 1, hypoactivity and piloerection persisting on day 2. accordingly, 200 and 500 mg/kg were chosen as doses for the main test.",,500 mg/kg group included the animal from the sighting test.,1 (subm. 3),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,hc yellow n° 2,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_038.pdf,,"at the low dose no mortalities were observed, at the mid dose no deaths were seen in the males while 3 of 5 females died within 8 h after dosing, at the high dose all animals died.",,,yes,at the mid dose 3/5 females dies within 8h after dosing and all animal died at high dose,,,,,,,,,10,suspension,,,,,,,rat/sprague-dawley,,,,f & m,,,,10,,"625, 1250, 2500",mg/kg bw,single dose,"yes, gavage",,,,,,,,,,,acacia,3,,,,the study did not follow modern standards. no data on the test substance were provided,1987,,no,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,hc yellow n° 13,OECD 401,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_044.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"the animals were observed daily for 14 days for clinical abnormalities and mortality. body weights and macroscopic observations were recorded. treatment caused lethargy, piloerection, abnormal posture and reduced righting reflex for up to 6 hours after dosing. ",,,"the animals were observed daily for 14 days for clinical abnormalities and mortality. body weights and macroscopic observations were recorded. treatment caused lethargy, piloerection, abnormal posture and reduced righting reflex for up to 6 hours after dosing. ",,,> 2000,,,,no,,no,,LD50 was greater than 2000 mg/kg bw,,,,,fluorgelb 2 in 2% gum grabic,99.7,,ar 902,,,rat/wistar crl: (wi)br,,,,,,,,f & m,,10,,2000,mg/kg bw ,10,single dose,,gum Arabic,2,14,,,1990,,yes,,3,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,hc yellow n° 13,OECD 402,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_044.pdf,,the animals were observed twice daily for 14 days for clinical abnormalities and mortality. body weights and macroscopic observations were recorded. chromodacryorrhea was noted in 3 males and 2 females. in 3 females body weight gain was lower than for controls. fur and tails were stained in all animals.,greater than 2000mg/kg bw/d,,no,, LD50 was reported to be greater than 2000 mg/kg bw,,,,,,,fluorgelb II moistened with distilled water ,,,99.7,,ar 902,,,,rat/sprague dawley him:ofa,,,,f & m,,,,10,,2000,mg/kg bw ,"single,",,yes,"the back, area of 5 x 6 cm",occluded,shaved area,,,,,,,distilled water,,24,14,,,1992,,yes,,,17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,hc red n° 7,OECD 420,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_007.pdf,,"hypoactivity, dyspnea and piloerection were observed within 4 hours of treatment in the animals given 2000 mg/kg. hypoactivity, then sedation, piloerection, dyspnea, purple urine and purple to purplish red coloration of the extremities (tail, ears, eyes, legs and nose) were observed prior to death.in the surviving female, hypoactivity or sedation, piloerection, dyspnea, purple urine and light red coloration of the extremities (ears, eyes, legs and nose) were noted on day 1 only.purple urine was noted in 1/5 females on day 1only. the overall body weight gain was not affected by treatment with the test item. at necropsy,no apparent abnormalities were observed. ",,,yes,"at 2000 mg/kg, the mortality was 3/5 (60%). at 300 mg/kg no mortality was observed",maximal non-lethal dose of hc red no. 7 (b036) (batch no. 0510149) of 300 mg/kg by the oral route in rats; 2000 mg/kg as the minimal lethal dose.,,,,,,,,99.3,,,,510149,,,,rat/ sprague-dawley rj:sd (iops han),,,,f,,,,5,,"300, 2000 ",mg/kg bw,,"yes, gavage",,,,,,,,20,,,carboxymethylcellulose in purified water,0.5,,,,"20 ml/kg is a high volume to be administered, especially of a solution containing carboxymethylcellulose. nevertheless, the substance is minimally toxic by ingestion of a single dose.",2004,,yes,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,hydroxypropyl bis(n-hydroxyethyl-p-phenylenediamine) HCl,OECD 401,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_011.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"the animals were observed daily for 14 days. bodyweights were recorded weekly and macroscopic abnormalities were recorded at autopsy. body weight gain of surviving animals was comparable to historical control data. the study authors concluded a LD50 of 2186 (1797 – 2965) mg/kg bw, with comparable toxicity in the males. clinical signs were reported in some animals of all dose groups from 30 minutes after dosing, and included: hypoactivity, sedation, piloerection and dyspnoea.  lateral decubitis was observed in one male animal. recovery was complete by day 5 for the males.",there were no macroscopic abnormalities at autopsy or in the animals found dead during the study. ,no histological examinations were performed,"the animals were observed daily for 14 days. bodyweights were recorded weekly and macroscopic abnormalities were recorded at autopsy. no histological examinations were performed.body weight gain of surviving animals was comparable to historical control data. the study authors concluded a LD50 of 2186 (1797 – 2965) mg/kg bw, with comparable toxicity in the males. clinical signs were reported in some animals of all dose groups from 30 minutes after dosing, and included: hypoactivity, sedation, piloerection and dyspnoea. recovery was complete by day 7 for the females. ",there were no macroscopic abnormalities at autopsy or in the animals found dead during the study. ,no histological examinations were performed,2186,1797 – 2965,,,yes,"at 2000 mg/kg bw, the mortality was 60% (3/5).  all deaths occurred within 30 minutes of dosing, except for one male (day 3). ",yes,"no mortalities were reported in the 1100 and 1600 mg/kg dose groups. at 2000 mg/kg bw, the mortality was 40% (2/5). four of the five females died after the dose of 2600 mg/kg bw.  all deaths occurred within 30 minutes of dosing, except for one female dosed at 2000 mg/kg bw (day 3). ",a121 was found to be moderately toxic to non-toxic via the oral route.,,,,,,99.8,,pil.4X,test substance: imexine oax in aqueous solution ,,rat/sprague-dawley,,,,,,,,f & m,,10,,"1100, 1600, 2000, 2600;  2000 ",mg/kg bw in females; in males,10,,gavage,,,14,,,,,yes,groups of 5 male and 5 female rats received a single dose of test substance by gastric gavage at 2000 mg/kg bw in a limit test,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,hydroxypropyl bis(n-hydroxyethyl-p-phenylenediamine) HCl,OECD 402,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_011.pdf,,"the animals were frequently observed during the hours following treatment and, thereafter, at least daily for a period of 14 days (clinical signs, mortality, body weight gain). a necropsy was performed on each animal killed at the end of the study. a necropsy was performed on each animal killed at the end of the study. at 2000 mg/kg no mortalities were reported. no changes in body weight gain or clinical signs - except for hypoactivity (in 1 out of 10 animals at 4 and 6 hours after treatment) - were observed. no cutaneous reactions were noted. there were no macroscopic anomalies at autopsy.",,,no,,a121 was found to be non-toxic via the dermal route,,,,,,,,99.8,,,,pil.4X,,test substance: imexine oax,,rat/sprague-dawley,,,,f & m,,,,10,,2000,mg/kg bw,,,yes,,"semi-occlusive dressing, moistened compress",,,,,,,,,,24,14,,,,,yes,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,basic red 51,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_067.pdf,,"clinical observations observed prior to death included hypoactivity, recumbency, irregular respiration, ataxia, and squinted eye. the 2 males from the lowest dose (500 mg/kg bw) survived until the scheduled sacrifice and gained weight during the course of the study. clinical observations in these animals included hypoactivity, irregular respiration, ataxia, squinted eyes, discoloured urine, faecal stains, and/or few faeces. most of these findings were resolved by day 3. at necropsy, no visible lesions were noted in the two males that survived in the 500 mg/kg dose group. in the animals that died, macroscopic findings involved the stomach, caecum, ileum, duodenum, jejunum, and/or colon. these were discoloured and/or distended filled with purple, red, or pink fluid.",,,yes,"most animals, except one female and 2 males at the lowest dose (500 mg/kg bw), died within the first 24 h of the experiment. the female died on day 1",,,,,,,,,,,97.2,,029753 a8aa,,test substance: mip 2985,,rat/crl:cd (sd)igs br,,,,f & m,,,,"4 , 10 ",,"500, 1000, 1500, 2000",mg/kg bw,single dose,"yes, gavage",,,,,,,,,,,cell culture grade water,,,14,,,"in a dose-limit test, the test substance was dissolved in cell culture grade water and administered by gavage as single doses of mip 2985 at 2000 mg/kg bw (5 rats per sex). the treatment-related mortality occurred at this dose. thus additional dose levels (500, 1000, 1500) were tested on 2 rats per sex per dose.",,yes,,,,,"4 animals(3 low doses), 10 animals (highest dose)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,basic red 51,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_067.pdf,,"3 males, including the two that died on day 1, were hypoactive and had roughened haircoat within 4 hours. macroscopic findings of the 2 males that died showed discoloured and/or distended stomach, caecum, ileum, duodenum, jejunum and bladder filled with purple, red, or pink fluid. 1 female was hypoactive and had liquid and/or mucoid faeces within 4h post-dosing. all surviving animals gained weight and showed no post-mortem anomalies at the end of the study",,,yes, 2 males receiving 500 mg/kg bw died on day 1. all other animals survived until the end of the experiment. ,,,,the acute oral LD50 was considered to be between 250 - 500 mg/kg bw in females and between 500 - 1000 mg/kg bw in males,,,,,,,97.2,,029753 a8aa,,test substance: mip 2985,,rat/ crl:cd (sd)igs br,,,,f & m,,,,5,,"250, 500",mg/kg bw,single dose,"yes, gavage",,,,,,,,,,,cell culture grade water,,,14,,,"in this small range-finding study, dosages were reduced.",,yes,,,1,,"5 male animal (high dose only), 5 female animal (low dose only)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,basic red 51,OECD 402,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_067.pdf,,"scoring time: the initial dermal irritation was scored and recorded 30 minutes after bandage removal on day 1. additional dermal irritation readings were performed for each animal on days 3, 7, 10, and 14. all animals were examined for clinical signs of ill health or mortality immediately post-dose and approximately 1, 2.5 and 4 hours post-dose, and daily thereafter. body weights were recorded pre-dose on the day of dosing (day 0), and on days 7 and 14, and prior to sacrifice on day 15 (fasted). a curtailed gross examination of the cervical, thoracic and abdominal viscera was performed. signs of clinical toxicity included chromodacryorrhea and/or red nasal discharge. findings were first noted 4 hours post-dose and were resolved by day 2. signs of dermal irritation included desquamation (slight scaling) in all males on day 3 and in one male and one female on day 7. there were no signs of dermal irritation at any observation interval in any of the remaining animals. all animals gained weight during the course of the study. No visible lesions were noted in any of the animals at necropsy",> 2000mg/kg bw,"LD50, mg/kg bw",no,,mildly irritating to the skin when applied dermally at a dose of 2000 mg/kg bw. there were also minor systemic effects. the acute dermal LD50 is greater than 2000 mg/kg bw,,,,,,,,,,97.2,,029753 a8aa,,test substance; mip 2985,,rat/ crl:cd (sd)igs br,,,,f & m,,,,20,,2000,mg/kg bw,single,,yes,on the back from scapula to iliac crest and half way down the flank on each side,occluded,hair was clipped the day prior to testing,,,,,,,moistened with distilled water,,24,14,,,,the untreated skin of each animal served as the control.,yes,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"1,5-naphthalenediol",OECD 423,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_033.pdf,,animals were subjected to daily observations and weekly determination of body weight. macroscopic examination was performed after terminal sacrifice. hunched posture and piloerection were noted in all animals on day 1. two males showed piloerection on day 2. the body weight gain shown by the animals over the study period was considered to be normal. no abnormalities were found at macroscopic post mortem examination of the animals.,,,no,,the oral LD50 value was established to exceed 2000 mg/kg bw,,,,,,,,,,> 99.9 ,,820211/01,,"test substance: 1,5-naphtalenediol",,"rat/wistar strain crl:(wi) br (outbred, spf-quality)",,,,f & m,,,,6,,2000,mg/kg bw,single dose,"yes, gavage",,,,,,,,,,,propylene glycol,,,15,,,,,yes,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"1,3,5-triazine, 2,4,6-tris(1,1'-biphenyl)-4-yl-",OECD 423,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_070.pdf,,"in 2/6 animals, body weight was slightly reduced. the body weight gain of the other animals was not affected by treatment with the test item. at necropsy, no apparent abnormalities were observed in any animals.",>2000 ,"LD50, mg test substance/kg bw, corresponding > 1000 mg eth50/kg bw.",no,,"under the conditions of this study the median lethal dose of the test substance after oral dosing was found to be greater than 2000 mg test substance/kg bw for female rats, corresponding to greater than 1000 mg eth50/kg bw.",,,,,,,,49.5 % of the active uv  filter eth50,test substance in  0.5% methylcellulose ,,,krg328-2,nano-sized material. particle size: d(0.5) = 81 nm. total particles dosed: 5.8x1014. surface area of particles dosed: 13.7 m2.,test substance: fat 65'080/e,,rat/ sprague dawley,,,,f,,,,3,,2000,mg/kg bw,single,"yes, gavage",,,,,,,,10,,,purified water,,,14,,,,,yes,,,1 (subm 3),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"1,3,5-triazine, 2,4,6-tris(1,1'-biphenyl)-4-yl-",OECD 403,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_070.pdf,,"the first satellite group was sacrificed about 14 hours post end of exposure for bronchoalveolar lavage fluid (BALF) and plasma sampling, the second group was assigned to interim pathology at approximately 24 hours post end of exposure (test day 2), and the third was assigned to pathology at 14 days post exposure (test day 15). all animals were observed for clinical signs and mortality during and following the inhalation exposure, i.e. until interim sacrifice or over a 15-day observation period. body weights were recorded before exposure on test day 1 in all animals and during the observation period on test days 4, 8 and 15 in all animals assigned to be sacrificed on day 15. the BALF examinations comprised total and differential cell counts and the determination of total protein, TNF-α and IL-6. in addition, total protein was determined in blood plasma from the animals assigned to BALF sampling. pathology examinations comprised complete macroscopic pathology, the determination of lung weight and histopathology of the lungs and tracheobronchial lymph nodes on days 2 and 15. test item: MMAD: 1.2 µm; median droplet volume cm³: 9.05E-19; number of particle a.i./L: 1.15E+12; approx. surface area (m²) / L: 0.0275. placebo: MMAD: 1.08 µm; median droplet volume cm³: 6.60E-19; number of particle a.i./L: --; approx. surface area (m²) / L: --. clinical signs attributable to treatment with the aqueous placebo dilution or test item dilution did not occur and no premature deaths occurred during the study. in BALF collected at about 14 hours after end of exposure the total cell count (mainly macrophage and neutrophil numbers), TNFα and total protein were considerably higher in both sexes of test item-treated animals than in placebo control animals, while total protein levels in plasma did not distinguish the two groups. the changes in BALF were consistent with the histopathology findings of granulocytic infiltration in alveolar wall and lumen, diffuse alveolar histiocytosis and alveolar lining cell activation seen in all test item-treated animals assigned to interim pathology at approximately 24 hours post end of exposure (test day 2). increases of total cell count, TNFα and total protein in BALF and of absolute and relative lung weight, and the histopathology findings of granulocytic infiltration, diffuse alveolar histiocytosis and alveolar lining cell activation seen in the test item group on test day 2 were attributed to the treatment with the test item. increase in neutrophil numbers in BALF on test day 2 was considered to be indicative of an inflammatory reaction. the study authors considered the findings noted in test item-treated animals on test day 2 to represent an acute clearance reaction to the lung burden of test item. this is further supported by the absence of these findings by test day 15. this response is well documented for particle exposures to lung (stone et al. 2007) and the cellular response is not characteristic of immunologic response profiles reflected in the low numbers of lymphocytes at day 2 and their absence histologically at day 15 (holt, p. et al. 2008) .",,,no,,"the applicant argued that such pulmonary inflammatory responses are not expected with use of eth50 in sunscreens or other products from spray-on dispensers. spray applicators are generally pump-type dispensers with some increase in marketed products using fine-spray aerosol type dispensers. in each of these applicators, the droplet sizes (aerosol) are designed to be at least 30 times larger than those used in this rat inhalation test. according to durand et al. (2007), sunscreen sprayable formulations should be dispensed with droplet size of more than 30 µm (mmad) with not more than 1% of droplets of aerodynamic diameter at or below 10 µm. the authors concluded that for nanosized eth50 the inhalation LC50 is greater than the highest technically achievable aerosol concentration level of 4.976 mg formulation/L air, or greater than 0.4976 mg eth50/L air, according to this study’s results with mmad of about 1.2 µm. a notable but reversible lung inflammatory response occurred which is considered a normal non-allergenic type response to particle exposures.",,,,,,,,"47.6 % of the active uv filter eth50,  the target concentration as active ingredient of uv filter eth50 was 10%. ",the test item and the placebo were prepared as aqueous dilutions at a ratio (w/w) of 20% fat65’080/f or 20% fat65’080-placebo plus 80% purified water,,,lot04122fc7,nano-sized material. d(0.5)=109 nm. two gravimetric measurements of particle size distribution during exposure indicated mass median aerodynamic diameters (MMADs) and geometric standard deviations (GSD) of 1.23 µm (GSD 2.13) and 1.27 µm (GSD 2.19). the particle size distribution was determined twice during each exposure using a mercer 7 stage cascade impactor (model 02-1300).,test substance: fat 65'080/f. ,,rat/ wistar [hanrcc:wist(spf)] ,,,,f & m,,,,30,,"4,976","chemically determined mean aerosol concentration of 4.976 mg of a formulation containing 10% eth50/L air (s.d. ± 0.513 mg/L air, n = 4), equivalent to a gravimetrically determined mean concentration of 0.602 mg eth50/L air (s.d. ± 0.059 mg/L air, n = 4). ",,,,,,,"yes, nose only flow-past",,,,,,,,4,14,,"the observed effects are similar to those observed upon inhalation of particulate materials in general including some nano-particles. however, the massive influx of neutrophils and the increase of macrophages by approximately a factor 2 cannot be considered to be merely a mild inflammation after inhalation of particles. none of the results in the cited reference stone et al. 2007 supports this conclusion. in contrary, these results presented here clearly indicate a strong inflammatory response of the host. the fact that even on day 15 a few parameters differed from those of the controls confirms this strong adverse reaction after inhalation of eth50 (109).",,"an additional group of 15 males and 15 females was exposed to an aqueous dilution of the control item, fat 65’080placebo, at aerosol generation conditions similar to those used for the test item ",yes,,,5 (subm 3),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"1,3,5-triazine, 2,4,6-tris(1,1'-biphenyl)-4-yl-",OECD 423,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_070.pdf,,"at 200 mg/kg bw, no clinical signs were observed. at 2000 mg/kg bw, piloerection and dyspnea, together with hypoactivity in females, were observed in all animals on day 1. when compared to historical control animals, a slight reduced body weight gain was recorded in 2/3 males given 200 mg/kg bw during the first or second week of the study. at 2000 mg/kg bw, a reduced body weight gain was noted in 1/3 females during the second week of the study. the overall body weight gain of the other animals was not affected by the treatment with the test substance.",,,,,under the conditions of this study the median lethal dose of the test substance after oral dosing was found to be greater than 2000 mg/kg bw for male and female rats.,,,,,,,,,,> 98,,eth  50/129b,,test substance: fat 65’080/a,,rat/ sprague dawley,,8,w,"m , f & m",,,,"3, 3+ 3",,"200, 2000 ","mg/kg bw in group 1 and 2, respectively",,"yes, gavage",,,,,,,,10,,,methylcellulose,0.5,,14,,,,,yes,,,1 (subm 1) annex 1,,"group 1: 3, group 2: 3+ 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"1,3,5-triazine, 2,4,6-tris(1,1'-biphenyl)-4-yl-",OECD 402,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_070.pdf,,a white coloration of the skin was noted in all animals on day 2. no other cutaneous reactions were recorded during the study.,,,,,"under the experimental conditions of this study, the median lethal dose of the test substance after topical dosing is higher than 2000 mg/kg bw in rats. no signs of toxicity were observed at this dose. ",,,,,,,,,,> 98,,eth  50/129b,,test substance: fat 65’080/a,,rat/ sprague dawley,,8,w,f &m,,,,10,,2000,mg/kg bw,,,yes,10% body surface,"hydrophilic gauze pad, under semi-occlusive dressing and restraining bandage ",,,,,,,,,,24,14,,,,,yes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"1-hydroxyethyl-4,5-diamino pyrazole sulfate",OECD 401,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_079.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,the animals were checked daily for mortality and clinical signs. body weights were recorded at start and on days 7 and 14. no mortality or any clinical signs of systemic toxicity were recorded in the test animals. orange coloured urine was observed in all animals. body weight gain was within a normal range.," in one male, large mesenteric lymph nodes and a grey-white covering on the spleen capsule were noted",,the animals were checked daily for mortality and clinical signs. body weights were recorded at start and on days 7 and 14. no mortality or any clinical signs of systemic toxicity were recorded in the test animals. orange coloured urine was observed in all animals. body weight gain was within a normal range.,,,>2000,,,,no,,no,,the acute oral LD50 in rats was greater than 2000 mg/kg bw,,,,,,99.1,,gst 4-20079,test substance: da 010894,,"rat/ him: ofa, sprague dawley, spf",,,,,,,,f & m,,10,,2000,mg/kg bw,10,single, intubation ,deionized water,,14,,,,,yes,,1,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"1-hydroxyethyl-4,5-diamino pyrazole sulfate",OECD 403,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_079.pdf,,"treatment-related effects included a slight to moderate decreased breathing frequency during exposure, grey discoloured areas on the lungs in half of the animals at necropsy, and discolouration of the fur of the animals, which was visible from just after exposure until necropsy 14 days later.",,,no,,the 4 h LC50 value of an aerosol of the test substance was larger than 5.24 g/m³ for both sexes,,,,,,,,,,99.8 ,,et046,the test material was milled before use to obtain an mmad in the range of 1-4 µm. the mass median aerodynamic (mmad) size of the particles in the test atmosphere was 3.3 µm and the distribution of particle sizes had a geometric standard deviation of 1.8. ,test substance: 18247 pyrazol ,,rat/wistar (crl:[wi]wu br),,,,f & m,,,,10,,5.24 ± 0.31,g/m³,single,,,,,,yes,,,,,,,,4,14,,,,,yes,,,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"2,4-diaminophenoxyethanol dihydrochloride and sulfate",OECD 401,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_035.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"clinical signs and mortality were checked daily for a period of 14 days following the single administration of the test item. the animals were checked for body weight gain on day 1, 8 and 15 and were subjected to necropsy. hypoactivity or sedation and piloerection were noted in all animals on day 1.  body weight gain in surviving animals was not affected by treatment with the test substance. no apparent abnormalities were observed at necropsy in all animals.", no apparent abnormalities were observed at necropsy in all animals.,,"clinical signs and mortality were checked daily for a period of 14 days following the single administration of the test item. the animals were checked for body weight gain on day 1, 8 and 15 and were subjected to necropsy. hypoactivity or sedation and piloerection were noted in all animals on day 1. lateral recumbency and tonic-clonic convulsions were also observed in two animals on day 1, one of these animals was found dead a few hours later. hypoactivity or sedation and piloerection persisted in the surviving animals up to day 3 or 4; dyspnoea and unsteady gait were recorded in the surviving females up to day 3.  body weight gain in surviving animals was not affected by treatment with the test substance.", no apparent abnormalities were observed at necropsy in all animals.,,≈ 1000,,,,yes,one male was found dead on day 2,yes,"two females were found dead on day 2, another female died on day 1 after a lateral recumbency and tonic-clonic convulsions ","under the experimental conditions, the LD50 of the test item was close to 1000 mg/kg bw, since a single dose of 1000 mg/kg bw induces death in 1/5 male and 3/5 female rats.",,,,,,99.6,,101297,"test substance: imexine oaj, test substance 2952 ",,rat/ sprague dawley ico:ofa-sd (iops caw) ,,,,,,,,f & m,fasted,10,,1000,mg/kg bw ,,single,gavage,,,14,,,,,yes,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"2,5,6-triamino-4-pyrimidinol sulfate",OECD 401 ,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_185.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,no mortality occurred. no clinical signs of toxicity were observed. the body-weight gain was not affected adversely during the study period,the macroscopic examination at terminal necropsy revealed no organ alterations,,no mortality occurred. no clinical signs of toxicity were observed. the macroscopic examination at terminal necropsy revealed no organ alterations. the body-weight gain was not affected adversely during the study period,the macroscopic examination at terminal necropsy revealed no organ alterations,,>2000,,,,no,,no,,the LD50 of the test substance administered to rats by the oral route was >2000 mg/kg bw,,,,,test substance homogenised in the vehicle ,,,,"test substance: 4-OH-2,5,6-triamino-pyrimidine sulphate",,rat/hanIbm: wist,,,,, 205-214,171-179,g,f & m,,10,,2000,mg/kg bw ,,single,gavage,corn oil,,14,,,,,yes,,3,1 (submission 1),guideline: oecd & eec 84/449/eec part b.1 ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"2,5,6-triamino-4-pyrimidinol sulfate",OECD 402,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_185.pdf,,"no mortality occurred. with the exception of scales and erythema at the site of application, no clinical signs of toxicity were observed. the macroscopic examination at terminal necropsy revealed no organ alterations",> 2000 ,"LD50, mg/kg bw",no,,the LD50 of the test substance administered to rats by the dermal route was > 2000 mg/kg bw,,,,,,,,,,,,,,"test substance: 4-OH-2,5,6-triamino-pyrimidine sulphate homogenised in corn oil ",,rat/hanIbm: wist,,,,f & m,219-239 / 202-215,gram male / female,,10,,2000,mg/kg bw ,single,,yes,,semi-occlusive,clipped intact skin,,,,,skin was washed with lukewarm tap water,,corn oil,,24,14,,,,,yes,,,2 (submission 1),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"2,6-diaminopyridine",OECD 423,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_084.pdf,,"body weight of animals was determined just before the administration and on days 2, 4, 8, 11 and 15 during the observation period. all study animals were autopsied after death. animals administered with 300 mg/kg of the test item showed extreme salivation, tremor, clonic and tonic convulsions, and died within approximately 1 hour. following the dose of 50 mg/kg bw salivation, paleness of skin and ptosis were observed. these changes were absent 4 hours after the administration; thereafter, any abnormalities were not observed from the next day of administration to the day of autopsy. body weight gain of 4/6 animals of the 50 mg/kg bw group was normal",50-300 ,"LD50, etween the mentioned numbers in mg/kg bw",no,,the LD50 was between 50-300 mg/kg bw,,,,,,,solid (dissolved in water),,,99.7,,a3221,,,,"rat/sprague-dawley [crl:cd (sd), spf]",,,,f,,,,9,,50; 300 ,mg/kg bw in step 2 and 3; in step 1,single dose,"yes, gavage",,,,,,,,,,,distilled water,,,15,,,2006,,yes,,,2,,stepwise process (3 animals/step),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"hydroxyethyl-3,4-methylenedioxyaniline HCl",non OECD ,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_006.pdf,,"clinical signs and mortality were checked daily for a period of 14 days following the single administration of the test item. body weights were recorded and all animals were submitted to a gross necropsy at the end of the observation period. decreased activity immediately after the application, staggering, piloerection and exitus (only as statement in the result section, no actual data reported).. at necropsy, no macroscopic organ changes were noted.",1550; 1650; 850,"LD50,  mg/kg bw in rat male, rat female; mouse female",yes,animals died within 2-72h after substance administration.,the following LD50 values were calculated using the method ofsSpearman-karber.,,,,,,,,10%,suspension test substance in vehicle,,,,,"test substance: 1-β-hydroxyethyl-3,4-methylenedioxybenzene suspended to 10% in a 10% gum arabic solution ",,rat/wistar crl: wi/br;  mouse/cf1,,,,rat: f & m / mouse: f,,,,10,,"1000, 1500, 2000, 2500;  500, 750, 1000, 1250 ",mg/kg bw in rats; in mice,single dose,"yes, gavage",,,,,,,,,,,gum arabic solution,10,,14,,,,,no,,,16,,guideline: but resembles OECD401,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,hc yellow n° 7,OECD 401,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_032.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"during the observation period of 14 days, a record was kept for mortalities and signs of toxicity. body weights were recorded on day 1 and then on days 8 and 15 for the surviving animals. surviving animals showed piloerection on day 1 or until day 3 (together with dyspnea and reduce activity for the latter rat). no mortalities and no clinical signs were observed at 50 mg/kg bw. no effect on the body weight was recorded in the surviving rats given 500 mg/kg bw. at 50 mg/kg bw, a reduced body weight gain was noted in 1/5 females during the first week of the study and in 1/5 females during the second week of the study when compared to historical control animals. ","all rats that died were investigated macroscopically to identify organ changes in the skull, thorax and abdomen and surviving animals were similarly examined at the end of the 14-day post-observation. at necropsy, no apparent abnormalities were observed in any animal.  ",,,,,500,,,yes,"at 500 mg/kg bw, 3 of the 5 female rats died on day 2. piloerection and orange-colored extremities were observed prior to death.",moderately toxic following a single oral administration. the results of the test indicated that the maximal non-lethal oral dose was 50 mg/kg in female rats and the minimal lethal dose was 500 mg/kg bw. 500 mg/kg bw is considered close to the median lethal dose (LD50).  ,,,solid,,,97.3,,509831,,,rat/sprague-dawley,,,,,,,,f,,5,,"50, 500 ",mg/kg bw,10,single,intubation,carboxymethylcellulose,0.5,14,,,2005,,yes,"one female was given 500 mg/kg preceded the definitive test. hypoactivity, dyspnea and piloerection were observed from day 1 to day 3 in the animal given 500 mg/kg bw. ",2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"2,6-diamino-3-((pyridin-3-yl)azo)pyridine ",non OECD ,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_065.pdf,"thymus, spleen, lymph nodes","the animals were checked daily for clinical signs and mortality. body weights were recorded at start and on days 7 and 14. all animals were submitted to a gross necropsy at the end of the observation period. results: the clinical signs noted at all doses were described as a general malaise including tremors, pale skin, dyspnoea, piloerection, excess salivation and lacrimation and possibly diarrhoea. these were considered vagotonic effects. the pinna and eyeballs were stained yellow in most animals at all doses. urine was also discoloured. these effects lasted up to 6 days in the surviving animals. at post mortem, haemorrhaging with major vascular ruptures were seen in many organs, possible causes of the small spleen and small thymus. enlarged spleens in surviving animals were considered to be due to reactive haematopoiesis. large lymph nodes may be due to reactive antigen penetration through damaged intestinal walls. no indication for impaired blood coagulation was noted. yellow/orange staining of the intestine and subcutaneous fat other fat was noted. there are no differences between the sexes. ",789,"LD50, mg/kg bw",yes,"at 346 mg/kg bw (male & female), mortality: no deaths. at 600 mg/kg bw (male & female), mortality: 3/5 on application day of each sex. at 1039 mg/kg bw (female), mortality: 2/5 females first day of dosing. at 1800 mg/kg bw (female), mortality: all died on application day. ",,,,,,,,,,test substance suspended in the vehicle,> 98,,l6/186 ,,test substance: da 100491,,"rat/sprague dawley, him:ofa, spf ",,,,f & m,,,,10,,"346, 600, 1039, 1800  ",mg/kg bw,single dose,"yes, gavage",,,,,,,,,,,aqueous solution of carboxymethylcellulose,0.5,,14,,,1993,,yes,,,13,,"guideline: EC Guideline 92/69, method B.1., 31 July 1992. the two lower doses were given to 5 males and 5 females each, whereas the two higher doses were only given to 5 females. ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"2,6-diamino-3-((pyridin-3-yl)azo)pyridine ",OECD 402 ,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_065.pdf,,urine was discoloured from day 3 to 6. the treated skin was stained yellow for the full study period. body weights were within the normal range. post-mortem showed no significant abnormalities. ,2000,"LD50, mg/kg bw",no,,"the LD50 for 2,6-diamino-3-((pyridine-3-yl)azo)pyridine was in excess of 2000 mg/kg bw following a single dermal application. ",,,,,,,,,test substance as a paste in water,99.7,,GST 4-11029 ,,test substance: da 100491 ,,rat/cd(sd)br,,,,f & m,,,,10,,2000,mg/kg bw ,single dose,,yes,≈10% of total body surface,occluded,shaved dorsal area,,,,,yes,,,,24,14,,,1996,,yes,,,14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,"2,6-dihydroxyethylaminotoluene",OECD 401,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_188.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,they were observed for 14 days after the day of dosing and were then killed for gross pathological examination. there were no mortalities and all animals showed the expected gain in bodyweight during the study. hunched posture and lethargy were noted in all animals on the day of dosing. ,no abnormalities were noted at necropsy.,,they were observed for 14 days after the day of dosing and were then killed for gross pathological examination. there were no mortalities and all animals showed the expected gain in bodyweight during the study. hunched posture and lethargy were noted in all animals on the day of dosing. ,no abnormalities were noted at necropsy.,,>2000,,,,no,,no,,LD50 of the test compound was found to be greater than 2000 mg/kg bw in rats.,,,solution,,test material as a suspension in distilled water,,,#2,test substance: a 138 ,,rat/sprague-dawley,,,,,140-152 ,129-140 ,g,f & m,,10,,2000,mg/kg bw,,single,gavage,,,14,,,,,yes,,1,1 (submission 1),"a limit test. the method used followed oecd guideline n° 401 (1981), referenced as method b1 in commission cirective 84/449/eec. ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,2-amino-4-hydroxyethylaminoanisole sulfate,non OECD,https://ec.europa.eu/health//sites/health/files/scientific_committees/consumer_safety/opinions/sccs_o_003.pdf,,"the animals were observed daily for clinical signs and mortalities for 14 days. bodyweights were recorded weekly and macroscopic abnormalities were recorded at autopsy. no histological examinations were performed. clinical signs noted were tonic spasm, piloerection, higher respiration rate in both rats and mice, but it was unclear if these occurred at all doses. surviving animals appeared normal thereafter. weight gain was normal for the strain used. autopsy of the animals surviving up to day 14 were reported to be normal. animals died between the first 24 hours and 6 days after dosing. the mortality rates are summarised for the different groups. at necropsy, no macroscopic organ changes/damages were noted.  based on the observed mortality, the following LD50 figures were calculated by the method of spearman-kärber LD50 rat, female: 588 mg/kg bw, LD50 rat, male: 475 mg/kg bw, LD50 mouse, female: 538 mg/kg bw.","588, 475; 538","LD50 mg/kg bw in rat female, in rat male; in mouse female",yes,"at dosages of 375 mg/kg bw and above, deaths in mice occurred within 48h, whilst in rats the deaths occurred mainly after 4-5 days. mortality in rats and mice after a single oral application; mice female: dose [mg/kg bw] 250: 0/10, 375: 2/10, 500: 6/10, 625: 5/10, 750: 9/10, 875: 10/10. rats female: dose [mg/kg bw] 250: 0/5, 375: 2/5, 500: 2/5, 625: 4/5, 750: 5/5, 875: -. rats male: dose [mg/kg bw] 250: 0/5, 375: 3/5, 500: 4/5, 625: 5/5, 750: 5/5, 875: -.","based on these findings, 1-methoxy-2-amino-4-ß-hydroxyethylamino-benzene-sulphate is considered as moderately toxic to rats and mice with LD50 values in the range of 475 to 588 mg/kg bw.",,,,,,,,,,,,,,test substance: 1-methoxy-2-amino-4-ß-hydroxyethylamino-benzene-sulphate.,,rat/ wistar; mouse/strain cf1,,,, f & m; f,,,,10,,"250, 375, 500, 625, 750 ; 250, 375, 500, 625, 750, 875 ",mg/kg bw rat; mouse,single,"yes, gastric gavage",,,,,,,,,,,aqueous preparation,10,,14,,the studies are not up to modern standards but the results give an indication of the LD50 in both rats and mice.,,,no,"doses selected for this study were based on pre-tests. 5 rats/sex were tested at a single dose of 875 mg/kg bw, all of them died. in female mice (10 per dose 250, 875 and 1500 mg/kg bw), a median lethal dose of less than 875 mg/kg bw was found.",,15,,2 test species,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,2-amino-4-hydroxyethylaminoanisole sulfate,OECD 401,https://ec.europa.eu/health//sites/health/files/scientific_committees/consumer_safety/opinions/sccs_o_003.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"mortality and clinical signs were checked daily for the 14-day observation period. the test substance caused dose related clinical signs to CNS, coordination, reflexes and autonomic functions increasing in severity up to 72 hours after dosing. weight gains were reduced in all surviving animals. ",,,"mortality and clinical signs were checked daily for the 14-day observation period. the test substance caused dose related clinical signs to CNS, coordination, reflexes and autonomic functions increasing in severity up to 72 hours after dosing. weight gains were reduced in all surviving animals. ",,,327,,333,351,yes,"animals died within 24-72 hours after dosing. Dose (mg/kg bw): number of dead animals, 125: 1/5, 250: 2/5, 500: 4/5, 750: 3/5, 1000: 5/5. ",yes,"animals died within 24-72 hours after dosing. mortality in mice after a single oral application; dose mg/kg bx): number of dead animals, 125: 1/5, 250: 1/5, 500: 3/5, 750: 5/5, 1000: 4/5.",lehmannblausulphat under the conditions of this study showed an LD50 of 327 mg/kg bw.,,,,1.25 – 10,test substance diluted in deionized water ,,,,test substance: lehmannblausulphat,,mouse/ bor: nmri white ,,,,,,,,f & m,,10,,"125, 250, 500, 750,1000 ",mg/kg,,single,gavage,deionised water,,14,,the studies are not up to modern standards but the results give an indication of the LD50 in mice.,,,yes,a preliminary range finding test with 2 female mice of 2000 mg/kg bw indicated that the median lethal dose was less than 2000 mg/kg bw as both died within 24 hours. ,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,2-amino-5-ethylphenol HCl ,OECD 423,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_085.pdf ,,"body weight of animals was determined just before the administration and on days 1, 8 and 15 during the observation period. all study animals were autopsied after death. slight to marked sedation was observed in all treated animals. ventral or lateral recumbency and cyanosis were noted in all rats. slight lacrimation, ruffled fur, hunched posture and orange urine were observed in the remaining 5 survival rats. these changes were absent 5 days after the administration. paleness of skin, muscle twitching and hypothermia were observed in 3 rats. padding movements were observed in 2 rats and tachypnea in one rats and disappeared 2-hours after administration. any abnormalities were not observed from the from test day 9 to the end of the study. the body weights of the animals were within the range commonly recorded for this strain and age. no macroscopic findings were recorded at necropsy, except in the animal killed in extremis in which the fatty tissue was slightly yellow.",> 2000,LD50 mg/kg bw,yes,one out of the 6 treated females was euthanized 2.5 h after treatment,"the acute toxicity of 2-amino-5-ethylphenol phosphate is low after single oral administration to female rats. the LD50 of 2-amino-5-ethylphenol phosphate is greater than 2000 mg/kg bw, corresponding to 1476 mg/kg bw as hydrochloride salt.",,,,,,,,,,99.9 area% (HPLC) ,,gst 079-03/52-09,,test substance: 2-amino-5-ethylphenol phosphate (wr 802433),,rat/hanrcc:wist (spf) ,,,,f,,,,3,,2000,mg/kg bw ,single,"yes, gavage",,,,,,,,10,,,purified water,,,15,,,23 november – 20 december 2005,,yes,,,13,,acute toxic classic method.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,2-hydroxyethylamino-5-nitroanisole,OECD 420,https://ec.europa.eu/health/ph_risk/committees/04_sccs/docs/sccs_o_001.pdf ,,"clinical signs and mortality were recorded and body weights were recorded on day 1, 8, and 15. all animals were sacrificed on day 15 and subjected to macroscopic examination. no mortality was observed at 500 mg/kg bw. hypoactivity or sedation, pilorection, dyspnea and yellow extremities were noted on day 1 in all animals. the overall body weight was not affected and macroscopic examination revealed no abnormalities.",,,,,the maximal non-lethal dose of the test substance was 500 mg/kg bw and the minimal lethal dose is 1000 mg/kg bw under the experimental conditions. ,,,,,,,,,test substance suspended in 0.5% methylcellulose,99.0,,507391,,test substance: 2-hydroxyethylamino-5-nitroanisole ,,rat/sprague-dawley rj: sd (iops han),,,,f,,,,5,,500,mg/kg bw,,"yes, gavage",,,,,,,,,,,,,,14,,,,,yes,"in an initial test, the test substance was administered at 1000 mg/kg bw. as mortality occurred at this dose, the dose of 500 mg/kg bw was chosen next. since no mortality occurred at this dose, the test substance was administered to 4 additional animals. ",,1,,taken from sccp/1099/07. fixed dose method. ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,2-methoxy-methyl-p-phenylenediamine and its sulfate salt ,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_123.pdf  ,,,,,,,LD50 rat (oral gavage): 150 – 200 mg/kg bw (free base: 91.5 – 122.0 mg/kg bw),,,,,,,,,,,,,,test substance: 2-methoxymethyl-p-phenylenediamine sulfate,,rat,,,,,,,,,,,mg/kg bw,,"yes, gavage",,,,,,,,,,,,,,,,,,,,,,"51, 53, 54",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,2-methoxy-methyl-p-phenylenediamine and its sulfate salt ,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_123.pdf   ,,,,,,,LD50 mice (intraperitoneal): 100 - 250 mg/kg bw,,,,,,,,,,,,,,test substance: 2-methoxymethyl-p-phenylenediamine sulfate,,mouse,,,,,,,,,,,mg/kg bw,,,,,,,,,intraperitoneal,,,,,,,,,,,,,,,"51, 53, 54",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,4-amino-2-nitrodiphenylamine-2'-carboxylic acid,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_058.pdf ,,"the animals were observed daily and body weights were recorded on days –1, 0, 2, 7 and 14 of the study. macroscopic examination of main organs was performed at autopsy. no histological examinations were performed. autopsy observations were discoloration of the intestines, subcutis and muscles and lung oedema. body weight gain for surviving animals was considered normal for the age and strain of rat. no abnormal findings were reported at scheduled autopsy.",> 2000,LD50 mg/kg bw,yes,there was one death in the male group which was assumed to be treatment-related (time after dosing not specified). ,the ld50 was reported to be greater than 2000 mg/kg bw. ,,,,,,,,,,98,,2495/127,,test substance: ro 1082,,rat/wistar albino ,,,,f & m,,,,9,,2000,mg/kg bw,single,"yes, gastric gavage",,,,,,,,,,,aqueous solution of carboxymethylcellulose +  cremophor,1 +  0.5,,14,,,1987,,yes,,,6,,"taken from sccnfp/0658/03, animals: 5males + 4 females",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,4-amino-2-nitrodiphenylamine-2'-carboxylic acid,OECD 402,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_058.pdf ,,"the animals were observed 1, 2 and 4 hours after dosing and thereafter daily for 14 days. body weights were recorded on days 1, 8 and 15 of the study. macroscopic examination of main organs was performed at autopsy. no histological examinations were performed. there were no mortalities. lethargy was noted in the majority of animals during the first 48 hours. body weight gain was considered to be low for the majority of animals during the first week of the study period and in one female in the second week. no skin irritation was observed on the exposed skin but discoloration due to the compound was noted throughout the study period. no abnormalities were noted at autopsy.",> 2000,LD50 mg/kg bw,no,,the dermal ld50 was reported to be in excess of 2000 mg/kg bw in both males and females. ,,,,,,,,,test substance suspended in 1% aqueous carboxymethylcellulose ,>95,,3962/46 ,,test substance: ro 1082 ,,"rat/wistar albino; outbred, spf",,,,f & m,,,,10,,2000,mg/kg bw,single,,yes,25 cm² for males and 18 cm² for females,occluded patch,,,,,,residue was removed with moistened tissue,,,,24,14,,,,,yes,,,"2, subm. 1",,taken from sccnfp/0658/03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,4-chlororesorcinol,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_016.pdf  ,,"during the observation period, a record was kept of mortalities and signs of toxicity. all rats that died were examined macroscopically to identify the target organs and surviving animals were similarly examined to detect possible damage. from the mortality data the ld50 and its 95% confidence limits were calculated. signs of reaction to treatment observed shortly after dosing, included lethargy, piloerection and decreased respiratory rate. these signs were accompanied by fine body tremors in rats treated at 160, 250 and 400 mg/kg, by ataxia in female rats at 160 and 400 mg/kg and all rats at 640 mg/kg, and by loss of righting reflex and coarse body tremors in rats at 640 mg/kg. death occurred from within one to two hours of treatment. autopsy revealed slight haemorrhage of the lungs, darkening of the liver, kidneys and spleen, and injection of mesenteric blood vessels. recovery of survivors, as judged by external appearance and behaviour was complete within two days of treatment. this observation was substantiated by normal body weight gains compared with controls and normal autopsy findings",369,LD50 mg/kg,yes,,the acute median lethal oral dose (ld50) and its 95% confidence limits to rats of 4- chlororesorcinol were calculated to 369 (314-433) mg/kg.,,,,,,,,10,test substance solution in aqueous sodium sulphite ,,,,,"test substance: 4-chlororesorcinol, 10 % solution in aqueous sodium sulphite (0.05%)",,rat/cfy strain,,,,f & m,95 - 122 ,g,starved overnight before treatment,10,,"0, 160, 250, 400, 640",mg/kg bw,,"yes, gavage",,,,,,,,1.6 - 6.4 ,,,aqueous sodium sulphite ,0.05%,,14,,,1975,rats treated with the vehicle alone (6.4 ml/kg bw) served as controls,,the results of preliminary range finding tests indicated that the median lethal oral dose (ld50 was in the region of 250 to 640 mg/kg bw.,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,4-nitrophenyl aminoethylurea,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_036.pdf  ,,"mortality and clinical signs were checked daily for the 14-day observation period. body weights were recorded weekly and all animals were submitted to a gross necropsy at the end of the observation period. in the main experiment clinical signs such as reduced activity and clonic-tonic spasms were noted in the mice at doses of 9000 and 11400 mg/kg bw within the first four hours after substance administration. in the rats, no clinical signs were observed. animals died within 2-24 hours (cf1 mice) and between 3 and 7 days (wistar rats) after substance administration. at necropsy, no macroscopic organ changes/damages were noted. based on the observed mortality rates, the following ld50’s were calculated using the method of spearman-kärber: ld50 rat (female): 8 g/kg bw, ld50 rat (male): > 8 g/kg bw, ld50 mouse (female): 7.32 g/kg bw","8, >8; 7.32","ld50 rat female, rat male; mouse female g/kg bw",yes,animals died within 2-24 hours (cf1 mice) and between 3 and 7 days (wistar rats) after substance administration. ,"the following ld50’s were calculated using the method of spearman-kärber: ld50 rat (female): 8 g/kg bw, ld50 rat (male): > 8 g/kg bw, ld50 mouse (female): 7.32 g/kg bw.",,,,,,,,,test substance suspended in vehicle,91.6,,ch. l4/130,,test substance: 1-(2-ureidoethyl)-amino-4-nitrobenzene,,rat/wistar strain;  mouse/cf1 ,,,, f & m; f,,,,12; 10,,"6000, 8000;  4200, 6600, 9000, 11400.",mg/kg bw rats; mouse,,"yes, gavage",,,,,,,,,,,gummi arabicum solution,10,,14,,"although the study was not performed in compliance with glp, the results are considered valuable for the evaluation of the acute oral toxicity of the test substance.",,,no,,,16,,"guideline: not indicated but in line with oecd 401. 2 tested species, 10 female mice per group, 12 male and female rats ( 6 male + 6 female)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,4-nitrophenyl aminoethylurea,OECD 402 ,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_036.pdf  ,,"clinical signs were noted at 10, 30 min, 1, 2, 4 and 6 hours after administration and at least once daily for the remaining 2 week observation period. body weight was determined before administration and on days 7 and 14 after administration of the test substance. the body weight gain was reduced in 2 females during the second week as compared to untreated animals. slight and temporary clinical signs, such as chromodacryorrhoea, were noted in 2 males and 1 female within 1 day after administration. yellow stained fur was observed in 1 male and all females post mortem.",> 2000,LD50 mg/kg bw,no,,the acute dermal toxicity study with 4-nitrophenylaminoethylurea in 5 male and 5 female rats revealed a dermal ld50 of > 2000 mg/kg bw.,,,,,"the test substance was moistened with distilled water immediately before testing,",,,,,99.0 ,,b1/89,,test substance: nitrogelb,,"rat/strain sprague dawley (him:ofa, spf)",,,,f & m,,,,10,,2000,mg/kg bw,,,yes,30 cm² (corresponding to at least 10% of the body surface) ,"cellulose patch, kept in place by a tape. the area was covered additionally by a fixomull dressing.",clipped dorsal skin free of hair the day before,,,,,tape and patch were removed and residual test substance was wiped off,,distilled water,,24,14,,,,,yes,,,17,,limit test study,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,5-amino-6-chloro-o-cresol,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_005.pdf   ,,"during the observation period of 14 days record was kept of mortalities and signs of toxicity twice a day. at the day of administration repeated observations have been made. already at the lowest dose of 0.5 g/kg all animals had signs of reaction to treatment like apathy, staggering, accelerated breathing and prone position. later on the animals suffered from hampered breathing. the excreted urine was coloured yellow-orange.",1.36,LD50 (1.21-1.54) g/kg,yes,no death occurred at a dose of 0.5 g/kg and one death at a dose of 1.00 g/kg. in the dose range of 1.25 to 1.99 g/kg 8 and 9 deaths respectively were observed. death occurred from within one to twenty four hours after treatment. ,"from these data, the acute median lethal dose (ld50) and its 95% confidence limits to rats of 2-chloro-6-methyl-3-aminophenol hydrochloride were calculated to 1.36 (1.21-1.54) g/kg.",,,,,,,,2.5 --> 9.95 ,test substance dissolved aqua dest,,,,,test substance: 2-chloro-6-methyl-3-aminophenol hydrochloride (ro 543),,rat/tno-wistar,,,,m,200g,,starved 16h before and 3 h after treatment,"10,  20 ",,"501, 1000, 1250, 1580 and 1990",mg/kg bw,,"yes, gavage",,,,,,,,20,,,aqua dest.,,,14,,the test substance (ro543) used in the acute oral toxicity test is not fully characterised. the study was conducted prior to glp and the respective oecd guideline. only one sex was tested.,1992,,no,,,4,,"20 animals for the 1250 mg/kg bw dose, all other doses 10 animals; ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,acid black 1,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_018.pdf  ,,"clinical signs noted 1 h after dosing, were piloerection, diarrhoea, prone/lateral position.",,,,,,,,,,,,,30,,,,,,test substance: acid black 10b,,rat/wistar 2,,,,f,,,,10,,"3.1, 10, 15, 16, 18", g/kg bw,,"oral, gavage",,,,,,,,,,,water,,,,,the results as presented are valueless as the table provided has transcriptional errors in it.,1974,,,,,1,,this study was provided as a 2004 certified translation with the comment that ‘the raw data documentation did not correspond to current standards. the doses started at higher concentration than the current guideline.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,acid black 1,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_018.pdf  ,,,"> 5,000",LD50 mg/kg bw,,,"the lethal dose (LD50) was > 5,000 mg/kg body weight. there were no symptoms of intoxication.",,,,,,,,,,,,,,test substance: acid black n° 1,,mouse/cf1 (winkelmann),,,,m,,,,10,,5000,mg/kg bw,single application,"oral, gavage",,,,,,,,20,,,bi-distilled water,,,,,,1983,,,,,2,,this study was provided as a 2005 certified translation.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,triclosan,non OECD,https://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_166.pdf,,"showed signs of slight cramps, exopthalmos, dyspnoea, and ventral decubitus, with recovery by 24 to 48 h after dosing.",19,LD50 mg/kg,,,,,,,,,,,,,,,,,,,mouse /nmri,,,,,,,,,,"10, 20",mg/kg,,,,,,,,,intravenous,,,,triethyleneglycol/water (1/2),,,,,,1968,,no,,,2,,"walther 1968a,predates glp and oecd ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,triclosan,non OECD,https://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_166.pdf,,,4350,LD50 mg/kg,,,"triclosan is not acutely toxic via the oral route of administration, with high oral intubation ld50",,,,,,,,,,,,,,,,mouse,,,,,,,,,,,,,"oral, gavage",,,,,,,,,,,,,,,,,1989,,no,,,1,,"desalva et al. glp and oecd status not reported, but some studies likely predate glp and oecd ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,triclosan,non OECD,https://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_166.pdf,,"mice in the intraperitoneal studies showed signs of general lethargy, lassitude, close huddling, lack of response to tactile stimuli and no increase in respiration rate and hyperactivity with death occurring between 6 and 72 hours. ",184,LD50 mg/kg,yes,,,,,,,,,,,,,,,,,,mouse/cd-1,,,,f,,,,,,,,,,,,,,,,intraperitoneal,,,,,,,,,,1982,,no,,,4,,"miller et al. Glp: not reported, oecd: not comparable",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,triclosan,non OECD,https://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_166.pdf,,"mice in the intraperitoneal studies showed signs of general lethargy, lassitude, close huddling, lack of response to tactile stimuli and no increase in respiration rate and hyperactivity with death occurring between 6 and 72 hours. ",1090,LD50 mg/kg,yes,,,,,,,,,,,,,,,,,,mouse /ddy,,,,m,,,,,,,,,,,,,,,,intraperitoneal,,,,,,,,,,1992,,no,,,5,,"kanetoshi et al. Glop: not reported, oecd: no comparable guidelines",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,triclosan,non OECD,https://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_166.pdf,,"showed signs of mydriasis, dyspnoea, and ventral decubitus, with recovery by 24 to 48 h after dosing.",29,LD50 mg/kg,,,,,,,,,,,,,,,,,,,rat/wistar cef,,,,,,,,,,"10, 20, 30",mg/kg,,,,,,,,,intravenous,,,,triethyleneglycol/water (1/2),,,,,,1968,,no,,,3,,"walther, 1968b; predates glp and oecd",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,triclosan,non OECD,https://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_166.pdf,,,3750 --> 5000,LD50 mg/kg,,,"triclosan is not acutely toxic via the oral route of administration, with high oral intubation ld50",,,,,,,,,,,,,,,,rat,,,,,,,,,,,,,oral gavage,,,,,,,,,,,,,,,,,1989,,no,,,1,,desalva et al. glp and oecd status not reported but some studies likely predate glp and oecd ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,triclosan,non OECD,https://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_166.pdf,,,> 9300,LD50 mg/kg,,,the data indicate that triclosan is not acutely toxic via the dermal route of administration. ,,,,,,,,,,,,,,,,rabbit,,,,,,,,,,,,,,dermal,,,,,,,,,,,,,,,,1989,,no,,,1,,"desalva et al. 1989,  glp and oecd status not reported but some studies likely predate glp and oecd ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,triclosan,non OECD,https://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_166.pdf,,,> 5000,LD50 mg/kg,,,"triclosan is not acutely toxic via the oral route of administration, with high oral intubation ld50",,,,,,,,,,,,,,,,dog,,,,,,,,,,,,,oral capsule,,,,,,,,,,,,,,,,,1989,,no,,,1,,desalva et al. 1989. glp and oecd status not reported but some studies likely predate glp and oecd ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,acid orange 7 ,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_158.pdf,,,> 10.000 (mouse and rat),LD50 mg/kg bw,,,the test substance is of very low acute oral toxicity. ,,,,,,,,,,,,,,,,in vivo,rat & mouse,,,,f (mouse),,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,,1,,taken from SCCS/1382/10. 2 species,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,acid orange 7 ,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_158.pdf,,,> 10.000,LD50 mg/kg bw,,,the test substance is of very low acute oral toxicity. ,,,,,,,,,,,,,,,,in vivo,rat,,,,f & m,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,,"2, 3, 4 ",,taken from SCCS/1382/10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,acid orange 7 ,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_158.pdf,,,"11,300",LD50 mg/kg bw,,,the test substance is of very low acute oral toxicity. ,,,,,,,,,,,,,,,,in vivo,rat,,,,f & m,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,,5,,taken from SCCS/1382/10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$
$startl$,acid orange 7 ,non OECD,https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_158.pdf,,,1,LD50 mg/kg bw,,,the test substance is of very low acute oral toxicity. ,,,,,,,,,,,,,,,,in vivo,dog,,,,,,,,,,,,yes,,,,,,,,,,,,,,,,,,,,,,5,,taken from SCCS/1382/10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,$endl$